<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1377090</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Role of hydrogen sulfide in the male reproductive system</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Song</surname>
<given-names>Yunjia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/703419"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Mao</surname>
<given-names>Caiyun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2608466"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhong</surname>
<given-names>Qing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Rong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jiang</surname>
<given-names>Deyou</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sun</surname>
<given-names>Xutao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine</institution>, <addr-line>Harbin</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Typhoid, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine</institution>, <addr-line>Harbin</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Synopsis of the Golden Chamber, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine</institution>, <addr-line>Harbin</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Guiming Liu, Northeast Ohio Medical University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Emma Mitidieri, University of Naples Federico II, Italy</p>
<p>Raffaella Sorrentino, University of Naples Federico II, Italy</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xutao Sun, <email xlink:href="mailto:sunxutao@hljucm.net">sunxutao@hljucm.net</email>; Deyou Jiang, <email xlink:href="mailto:jiangdeyou@126.com">jiangdeyou@126.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1377090</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Song, Mao, Zhong, Zhang, Jiang and Sun</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Song, Mao, Zhong, Zhang, Jiang and Sun</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>As an important gas signaling molecule, hydrogen sulfide (H<sub>2</sub>S) affects multiple organ systems, including the nervous, cardiovascular, digestive, and genitourinary, reproductive systems. In particular, H<sub>2</sub>S not only regulates female reproductive function but also holds great promise in the treatment of male reproductive diseases and disorders, such as erectile dysfunction, prostate cancer, varicocele, and infertility. In this review, we summarize the relationship between H<sub>2</sub>S and male reproductive organs, including the penis, testis, prostate, vas deferens, and epididymis. As lower urinary tract symptoms have a significant impact on penile erection disorders, we also address the potential ameliorative effects of H<sub>2</sub>S in erectile dysfunction resulting from bladder disease. Additionally, we discuss the regulatory role of H<sub>2</sub>S in cavernous smooth muscle relaxation, which involves the NO/cGMP pathway, the RhoA/Rho-kinase pathway, and K<sup>+</sup> channel activation. Recently, various compounds that can alleviate erectile dysfunction have been reported to be at least partly dependent on H<sub>2</sub>S. Therefore, understanding the role of H<sub>2</sub>S in the male reproductive system may help develop novel strategies for the clinical treatment of male reproductive system diseases.</p>
</abstract>
<kwd-group>
<kwd>erectile dysfunction</kwd>
<kwd>H2S</kwd>
<kwd>testis</kwd>
<kwd>prostate cancer</kwd>
<kwd>oxidative stress</kwd>
<kwd>bladder</kwd>
</kwd-group>
<contract-sponsor id="cn001">China Postdoctoral Science Foundation<named-content content-type="fundref-id">10.13039/501100002858</named-content>
</contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="137"/>
<page-count count="14"/>
<word-count count="8236"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Reproduction</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>In recent years, the incidence of male reproductive system diseases has increased, attracting substantial attention from researchers worldwide. Male reproductive system diseases primarily affect the penis, testis, prostate, vas deferens, and epididymis (<xref ref-type="bibr" rid="B1">1</xref>). Various microorganisms, environmental factors, and long-term smoking or alcohol abuse may affect male reproductive function (<xref ref-type="bibr" rid="B2">2</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>), leading to diseases such as erectile dysfunction (ED) (<xref ref-type="bibr" rid="B6">6</xref>), prostate cancer (PCa) (<xref ref-type="bibr" rid="B7">7</xref>), varicocele (<xref ref-type="bibr" rid="B8">8</xref>), and infertility (<xref ref-type="bibr" rid="B9">9</xref>). Studies have shown that oxidative stress is an important factor contributing to the occurrence and development of these diseases. However, owing to the complex pathogenesis of male reproductive system diseases, the corresponding treatment strategies are not well-established. Therefore, identifying precise targets is necessary to optimize the diagnosis and treatment of male reproductive system diseases.</p>
<p>H<sub>2</sub>S is the third major gas signaling molecule after nitric oxide (NO) and carbon monoxide (CO) and possesses strong antioxidant activity (<xref ref-type="bibr" rid="B10">10</xref>). It is involved in the regulation of important pathophysiological processes, including inflammation, oxidative stress, autophagy, and apoptosis, in the cardiovascular, nervous, and digestive systems (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). In addition, recent studies have shown that H<sub>2</sub>S affects the reproductive system in both men and women. H<sub>2</sub>S regulates female reproductive function through K<sup>+</sup> channels and various signaling pathways, including the ERK1/2/NF-&#x3ba;B and Nrf2 pathways (<xref ref-type="bibr" rid="B13">13</xref>), and exerts protective effects on the male reproductive system. It plays an important role in early spermatogenesis and late maturation of spermatogenic cells and may prevent damage to the reproductive system by promoting the proliferation of spermatogonia, regulating the corpus cavernosum (CC) of the penis, and mediating erection as well as other related functions (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>). In this review, we summarize the relationship between H<sub>2</sub>S and the male reproductive system, discuss the pathological mechanisms of male reproductive system diseases, and propose novel strategies for the early diagnosis (<xref ref-type="bibr" rid="B17">17</xref>) and prompt treatment of these diseases.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Distribution of H<sub>2</sub>S synthases in the male reproductive system</title>
<p>Endogenous H<sub>2</sub>S is produced from L-cysteine (L-Cys) via desulfurization catalyzed by cystathionine &#x3b3;-lyase (CSE) and cystathionine &#x3b2;-synthase (CBS) or from 3-mercaptopyruvate via 3-mercaptopyruvate sulfurtransferase (3-MPST) (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). 3-mercaptopyruvate is derived from two sources as follows: L-Cys via cysteine aminotransferase (CAT) (CAT/3-MPST pathway) and D-cysteine via amino acid oxidase (DAO) (DAO/3-MPST pathway) (<xref ref-type="bibr" rid="B20">20</xref>). A study reported that H<sub>2</sub>S exhibited specificity to vascular smooth muscle (<xref ref-type="bibr" rid="B21">21</xref>), which may be related to differences in the mechanisms of H<sub>2</sub>S production. Given that endogenous H<sub>2</sub>S is synthesized through various pathways, the distribution of H<sub>2</sub>S synthases in various parts of male reproductive organs (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>) may indicate the source and production mode of H<sub>2</sub>S.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Distribution of H<sub>2</sub>S synthases in the male reproductive system.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1377090-g001.tif"/>
</fig>
<p>Srilatha et&#xa0;al. (<xref ref-type="bibr" rid="B22">22</xref>) detected the presence of endogenous H<sub>2</sub>S in smooth muscle tissue homogenates from the CC of rabbits. Although they used rabbit CC and did not identify the exact source of H<sub>2</sub>S, their study was the first to show that H<sub>2</sub>S can be produced in the penis. Subsequently, d&#x2019;Emmanuele et&#xa0;al. (<xref ref-type="bibr" rid="B23">23</xref>) evaluated the mRNA and protein expression of CBS and CSE in&#xa0;human corpus cavernosum (HCC) and validated that endogenous&#xa0;H<sub>2</sub>S was produced in HCC by the two enzymes. Immunohistochemical analysis showed that CSE was located in vascular smooth muscle cells (SMCs) in the penile artery, bundles of muscular tissue in HCC trabeculae, and peripheral nerves, whereas CBS was primarily located in bundles of muscular tissue in trabeculae. Furthermore, CBS and CSE have been found in human prostate tissue sections. CBS is mainly expressed in the glandular lumen and epithelial cells of the prostate, whereas CSE is distributed in the SMCs of the periacinar stroma (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). These experimental results suggest that H<sub>2</sub>S is predominantly synthesized by CSE instead of CBS in male reproductive organs.</p>
<p>The tissue samples used in most existing studies have been derived from animals, such as rats and mice. However, the species and location of H<sub>2</sub>S synthases in animals are different from those in humans. In rats, all five H<sub>2</sub>S synthases, namely, CSE, CBS, CAT, DAO, and 3-MPST, are expressed in penile tissues at both mRNA and protein levels; however, CBS is not expressed in corpus cavernosum smooth muscle cells (CCSMCs) (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). The mRNA expression of the five enzymes has been detected at two specific sites in rat prostate tissues (dorsolateral [PR-D] and ventral [PR-V]); however, these sites lack the protein expression of CSE and DAO. In particular, the expression of CBS is substantially higher in PR-V than in PR-D, the expression of 3-MPST is higher in PR-D than in PR-V, and the expression of CAT is similar between the two sites. Additionally, immunoreactivity of CBS, 3-MPST, and CAT has been observed primarily in rat glandular epithelial cells (<xref ref-type="bibr" rid="B19">19</xref>). In mice, CBS, CSE, and 3-MPST are primarily expressed in the CC (<xref ref-type="bibr" rid="B28">28</xref>). CSE is located in the endothelial cells of the cavern and vessels in the CC, with its expression being higher than that of CBS and 3-MPST. CBS is located in the cavernous subendothelial smooth muscle, vascular smooth muscle, and peripheral nerves, whereas CSE and 3-MPST are not found at these sites (<xref ref-type="bibr" rid="B29">29</xref>). A study showed that the expression of CSE in mouse prostate tissues substantially decreased with age, whereas that of CBS remained unaffected. Moreover, knockout of CSE reduced the production of H<sub>2</sub>S by approximately 80%, indicating that H<sub>2</sub>S is predominantly synthesized by CSE in the mouse prostate (<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>To the best of our knowledge, studies investigating the effects of H<sub>2</sub>S on the testis have used only experimental animal models; therefore, related data on human tissues are not yet available. In rats, CBS is abundant in Leydig and Sertoli cells, which can be observed in the interstitial space and basement membrane of seminiferous tubules, respectively. In addition, its expression is moderate in the immature reproductive cells of the peripheral region of the tubules but very low in the mature reproductive cells of the central region of the tubules. CSE is found in vascular walls in the interstitial space of the testis, Sertoli cells, and immature reproductive cells (<xref ref-type="bibr" rid="B31">31</xref>). CBS, CSE, and 3-MPST are expressed in the testis and germ cells in mice (<xref ref-type="bibr" rid="B32">32</xref>). Data on the vas deferens (VD) are scarce. A study on humans, rats, and mice showed that the expression of CSE and CBS was high in the luminal epithelium and smooth muscle of VD (<xref ref-type="bibr" rid="B33">33</xref>). Furthermore, the mRNA expression of CBS and CSE is high in the body and tail regions of rat epididymis (<xref ref-type="bibr" rid="B34">34</xref>). In particular, CBS is found in epididymal epithelial cells, whereas CSE is found in the thin layer of SMCs underneath the epididymal epithelium. These findings suggest that species-specific differences should be considered when using animals to investigate the effects of H<sub>2</sub>S on the reproductive system.</p>
</sec>
<sec id="s3">
<label>3</label>
<title>Effects of H<sub>2</sub>S on the male reproductive system</title>
<sec id="s3_1">
<label>3.1</label>
<title>Effects of H<sub>2</sub>S on the penis</title>
<sec id="s3_1_1">
<label>3.1.1</label>
<title>Regulation of mechanisms underlying penile erection</title>
<p>Erection is a neurovascular event whose form and function mostly depend on the relaxation of the cavernous smooth muscle and arteries in the penis. When parasympathetic nerves are stimulated to release neurotransmitters, the smooth muscle of HCC (a highly vascularized structure) and human penile resistance arteries relax. Subsequently, blood flows into the cavernous sinuses and inflates them, which in turn pressurizes the veins to reduce blood outflow and increases intracavernosal pressure (ICP), eventually leading to penile erection (<xref ref-type="bibr" rid="B35">35</xref>). Altogether, arterial blood flow exceeding venous blood return causes and maintains normal penile erection, with smooth muscle relaxation playing a key role in the process.</p>
<p>The neurotransmitter-like regulatory effects of H<sub>2</sub>S on vascular smooth muscle have been reported in previous studies (<xref ref-type="bibr" rid="B36">36</xref>). Srilatha et&#xa0;al. (<xref ref-type="bibr" rid="B37">37</xref>) were the first to demonstrate that H<sub>2</sub>S has a neuroregulatory effect on penile erection. They examined the effects of exogenous H<sub>2</sub>S on the penis by injecting sodium hydrosulfide (NaHS) into the CC of non-human primates. The results showed that both penile length and ICP were remarkably increased, and the changes before erection were similar to those observed in the positive control group (injected with prostaglandin E1). Furthermore, injection of DL-propargyl glycine (PAG, a CSE inhibitor) into the external jugular vein of rats notably weakened the ICP induced by electrical stimulation of the cavernous nerve with platinum wire electrodes. These findings suggest that neuronal excitation induces the release of H<sub>2</sub>S to mediate penile erection. The detection of CSE in the human peripheral penile nerve supports these findings (<xref ref-type="bibr" rid="B23">23</xref>). In addition, Jupiter et&#xa0;al. (<xref ref-type="bibr" rid="B38">38</xref>) demonstrated that exogenous H<sub>2</sub>S promoted penile erection in rats.</p>
<p>At present, the exact mechanism through which H<sub>2</sub>S relaxes the cavernous smooth muscle remains unclear. The previously reported mechanisms include synergistic action of H<sub>2</sub>S with NO, activation of K<sup>+</sup> channels, and regulation of the RhoA/ROCK pathway (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>); among which, the first mechanism is the most controversial. NO is considered the primary mediator of erectile function (<xref ref-type="bibr" rid="B56">56</xref>). Endogenous NO is generated by NO synthase (NOS) from L-arginine and consists of three isoforms as follows: neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS) (<xref ref-type="bibr" rid="B57">57</xref>). NO increases cGMP levels by activating soluble guanylate cyclase (sGC); subsequently, cGMP acts as a second intracellular messenger to regulate calcium channels and contractile proteins involved in the relaxation of cavernous smooth muscle (<xref ref-type="bibr" rid="B58">58</xref>). As early as 1997, Hosoki et&#xa0;al. (<xref ref-type="bibr" rid="B59">59</xref>) proposed the possibility of synergism between H<sub>2</sub>S and NO. They found that 100-&#x3bc;M NaHS had a weak effect on relaxing thoracic aortic smooth muscle in rats; however, when administered in the presence of 10-nM sodium nitroprusside (SNP, an NO donor), NaHS strongly relaxed the smooth muscle. Similarly, in the presence of 30-&#x3bc;M NaHS, SNP increased the relaxation of thoracic aortic smooth muscle by 13 times.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Effects of H<sub>2</sub>S on the male reproductive system.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Organ</th>
<th valign="top" align="left">Action</th>
<th valign="top" align="left">Mechanisms</th>
<th valign="top" align="left">Models</th>
<th valign="top" align="left">References</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="12" align="left">Penis</td>
<td valign="top" rowspan="11" align="left">Promotion of erection</td>
<td valign="top" align="left">Activation of the RhoA/ROCK pathway and K<sub>ATP</sub> channel</td>
<td valign="top" align="left">HCC strips from transsexual operation (n = 6)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B23">23</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Activation of the sGC/cGMP pathway</td>
<td valign="top" align="left">CC strips from men with ED (n = 50)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B39">39</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Activation of the NO/sGC/cGMP pathway</td>
<td valign="top" align="left">CSE<sup>-/-</sup> mice</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B16">16</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Activation of the RhoA/ROCK pathway</td>
<td valign="top" align="left">Mouse CC strips</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B40">40</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Dependent on cAMP or cGMP</td>
<td valign="top" align="left">Rabbit CC strips (n = 5)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B22">22</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Activation of the BKCa channel</td>
<td valign="top" align="left">Anesthetized rats</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B38">38</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Activation of BKCa and Kv channels</td>
<td valign="top" align="left">Rat CC strips</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B41">41</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Increased eNOS expression</td>
<td valign="top" align="left">L-NAME-induced hypertensive rats (n = 40)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B42">42</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Increased NO levels and HO activity</td>
<td valign="top" align="left">Diabetic rats (n = 90)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Activation of the RhoA/ROCK pathway</td>
<td valign="top" align="left">Rats with bilateral cavernous nerve injury (n = 18)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B44">44</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Activation of the NO/sGC/cGMP pathway and K<sub>ATP</sub> channel</td>
<td valign="top" align="left">Rats with STZ-induced diabetes (n = 10 or 12)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B45">45</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Improve vascular injury of CC</td>
<td valign="top" align="left">Inhibition of the TGF-&#x3b2;1/Smad/CTGF pathway</td>
<td valign="top" align="left">Rats with STZ-induced diabetes</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B46">46</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Prostate</td>
<td valign="top" align="left">Inhibition of CRPC</td>
<td valign="top" align="left">S-sulfhydration of AR</td>
<td valign="top" align="left">CSE knockout and overexpression in LNCaP cells and LNCaP-B cells</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B30">30</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Promotion of NE differentiation</td>
<td valign="top" align="left">Increased activity of Cav3.2</td>
<td valign="top" align="left">LNCaP cells</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B47">47</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="7" align="left">Testis</td>
<td valign="top" align="left">Reduce sperm motility</td>
<td valign="top" align="left">Activation of AMPK/Akt-related pathways</td>
<td valign="top" align="left">Boar sperm; NH<sub>4</sub>Cl- and/or Na<sub>2</sub>S-treated mice</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B48">48</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="3" align="left">Alleviate the apoptosis of testicular germ cells</td>
<td valign="top" align="left">Increased SOD activity and reduced Bax/Bcl-2 ratio</td>
<td valign="top" align="left">Mice subjected to heat exposure</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B32">32</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Reduction of iNOS, TNF-&#x3b1;, and Apaf-1 levels</td>
<td valign="top" align="left">Rats with testicular torsion-induced I/R injury (n = 38)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B49">49</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Activation of the Keap1/Nrf2 signaling pathway</td>
<td valign="top" align="left">GC-2spd(ts) cells derived from mouse spermatocytes</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B50">50</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Alleviate testosterone synthesis</td>
<td valign="top" align="left">S-sulfhydration of PDE4A/8A and activation of the cAMP/PKA pathway</td>
<td valign="top" align="left">Mouse Leydig tumour cells with LPS + H2O2-induced testosterone synthesis impairment</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B51">51</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Increase sperm motility</td>
<td valign="top" align="left">Activation of the CBS/H<sub>2</sub>S pathway</td>
<td valign="top" align="left">Mice with LPS- and diabetes-induced sperm dysfunction and CBS<sup>+/&#x2010;</sup> mice</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B52">52</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">ROS scavenging</td>
<td valign="top" align="left">Fe<sup>2+</sup>/ascorbate-treated boar sperm</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B53">53</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Epididymis</td>
<td valign="top" align="left">Alleviate varicocele-induced epididymis injury</td>
<td valign="top" align="left">Activation of the PI3K/Akt pathway</td>
<td valign="top" align="left">Experimental varicocele rat model (n = 60)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B54">54</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Maintain quiescence of epididymal sperm</td>
<td valign="top" align="left">Activation of K<sub>ATP</sub> and BKCa channels</td>
<td valign="top" align="left">Cauda epididymal epithelium cells</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B34">34</xref>)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Vas deferens</td>
<td valign="top" rowspan="2" align="left">Regulation of VD spontaneous contraction</td>
<td valign="top" align="left">Activation of the L-Cys/H<sub>2</sub>S pathway</td>
<td valign="top" align="left">Human VDs from monorchidism surgery (n = 3); rat VDs (n = 20); mouse VDs (n = 11)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B33">33</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Activation of BKCa channel</td>
<td valign="top" align="left">Rat VDs</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B55">55</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Akt, protein kinase B; AMPK, adenosine 5&#x2019;-monophosphate AMP-activated protein kinase; Apaf-1, apoptosis protease-activating factor-1; BKCa, large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel; CRPC, castration-resistant prostate cancer; cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; CTGF, connective tissue growth factor; CC, corpus cavernosum; ED, erectile dysfunction; NOS, NO synthase; ERK1/2, extracellular signal-regulated kinase &#xbd;; HCC, human corpus cavernosum; HO, heme oxygenase; Keap1, Kelch-like ECH-associated protein 1; L-NAME, n&#x3c9;-nitro-L-arginine; L-Cys, L-cysteine; LPS, lipopolysaccharide; NE, neuroendocrine; PCa, prostate cancer; Nrf2, nuclear factor erythroid 2-related factor 2; PI3K, phosphatidylinositol 3&#x2019;-OH kinase; ROCK, Rho-kinase; sGC, soluble guanylate cyclase; SOD, superoxide dismutase; STZ, streptozotocin; VD, vas deferens.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>On the contrary, the results of some studies on CC do not support the synergism between NO and H<sub>2</sub>S. Srilatha et&#xa0;al. (<xref ref-type="bibr" rid="B22">22</xref>) incubated noradrenaline-precontracted rabbit cavernosum tissue strips with n<sup>&#x3c9;</sup>-nitro-L-arginine (L-NAME, a non-selective NO synthase inhibitor) and subsequently treated them with NaHS (100 &#x3bc;M&#x2013;3.2 mM). The results showed that muscle relaxation induced by NaHS was not affected by L-NAME. Furthermore, the strips were precontracted in the presence of guanethidine and atropine and incubated with aminooxyacetic acid (AOAA, a CBS inhibitor) and &#x3b2;-cyanoalanine (&#x3b2;-CA, a CSE inhibitor) or PAG, respectively. After electrical stimulation, H<sub>2</sub>S inhibitors did not affect non-adrenergic, non-cholinergic nitrergic (NANC) relaxation. Similarly, L-NAME had minimal inhibitory effects on muscle relaxation induced by NaHS (1 &#x3bc;M&#x2013;10 mM) (<xref ref-type="bibr" rid="B23">23</xref>). A study on live rats showed that intracavernosal injection of sodium sulfide (Na<sub>2</sub>S, 0.03&#x2013;1 mg/kg) increased ICP, whereas intravenous injection of L-NAME had no considerable effect on ICP (<xref ref-type="bibr" rid="B38">38</xref>). Moreover, intracavernosal injection of Na<sub>2</sub>S did not alter the SNP-induced erectile response. In mouse CC, NO deficiency may increase the expression of CSE and 3-MPST, leading to an increase in the production of H<sub>2</sub>S and H<sub>2</sub>S-induced muscle relaxation (<xref ref-type="bibr" rid="B28">28</xref>). This effect may be compensatory and disproves that the relaxation effects of H<sub>2</sub>S are dependent on NO. Altogether, the abovementioned findings indicate that H<sub>2</sub>S does not promote penile erection through synergism with NO.</p>
<p>Some studies investigating the relationship between H<sub>2</sub>S and NO in the CC tissue support the synergy between them. H<sub>2</sub>S has been shown to increase the expression of NOS. Meng et&#xa0;al. (<xref ref-type="bibr" rid="B39">39</xref>) showed that the mRNA and protein levels of eNOS were remarkably higher in rat CC tissues treated with NaHS than in untreated tissues, whereas those of nNOS were not considerably different between treated and untreated tissues. Yilmaz et&#xa0;al. (<xref ref-type="bibr" rid="B42">42</xref>) showed that L-NAME decreased the protein expression of eNOS and nNOS in the penile tissues of hypertensive rats, whereas addition of NaHS (0.037 mg/kg) prevented this change. Consistent with these two studies, another study showed that NaHS (30 mg/kg) increased NO levels in rat CC tissues (<xref ref-type="bibr" rid="B43">43</xref>). Furthermore, H<sub>2</sub>S has been shown to increase the activity of eNOS. Meng et&#xa0;al. (<xref ref-type="bibr" rid="B39">39</xref>) showed that eNOS notably increased the production of NO from L-arginine by 5 times in more than rat CC tissues treated with NaHS (1 mM), suggesting that H<sub>2</sub>S enhanced the activity of eNOS. Knockout of CSE may not alter total eNOS levels but may remarkably reduce the levels of its active form p-eNOS (<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>These contradictory findings suggest that tissue- and species-specific crosstalk exists between H<sub>2</sub>S and NO and the mechanism through which H<sub>2</sub>S relaxes the cavernous smooth muscle is independent of the NO/cGMP signaling pathway. Endogenous H<sub>2</sub>S can inhibit the targeted degradation of cGMP by inhibiting phosphodiesterase (PDE) (<xref ref-type="bibr" rid="B60">60</xref>). Several studies have demonstrated that H<sub>2</sub>S in the penis regulates cGMP levels by acting on sGC. Stimulation of HCC with both endogenous and exogenous H<sub>2</sub>S (L-Cys [1 &#x3bc;M&#x2013;1 mM] and NaHS [1 &#x3bc;M&#x2013;1 mM], respectively) increases cGMP levels, which may be restored upon treatment with 1H-[1,2,4]oxadiazolo[4,3-a] quinoxalin-1-one (ODQ, an sGC inhibitor) (<xref ref-type="bibr" rid="B61">61</xref>). The reduction of H<sub>2</sub>S levels in CSE-knockout mice results in an impaired redox state of sGC, decreasing cGMP levels in the penis (<xref ref-type="bibr" rid="B16">16</xref>). These findings suggest that H<sub>2</sub>S bypasses NO to upregulate cGMP and hence affects its downstream signaling.</p>
<p>The four primary types of potassium (K<sup>+</sup>) channels expressed in arterial smooth muscle cells include Ca<sup>2+</sup>-activated (KCa), adenosine triphosphate (ATP)-sensitive (K<sub>ATP</sub>), inwardly rectifying (Kir), and voltage-gated (Kv) channels (<xref ref-type="bibr" rid="B62">62</xref>). The relaxation effects of H<sub>2</sub>S on vascular SMCs isolated from rats have been shown to rely on the K<sub>ATP</sub> channel (<xref ref-type="bibr" rid="B21">21</xref>). The four K<sup>+</sup> channels have also been detected in HCC (<xref ref-type="bibr" rid="B63">63</xref>). To examine the role of these K<sup>+</sup> channels in H<sub>2</sub>S-mediated responses in CC, Jupiter et&#xa0;al. (<xref ref-type="bibr" rid="B38">38</xref>) injected tetraethylammonium (TEA, a non-selective K<sup>+</sup> channel inhibitor), iberiotoxin (a large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> [BKCa] channel inhibitor), and glybenclamide (GLB, a K<sub>ATP</sub> channel inhibitor) into the CC of anesthetized rats and examined their effects on Na<sub>2</sub>S (0.03&#x2013;1 mg/kg)-induced changes in ICP. The results showed that intracavernosal injection of Na<sub>2</sub>S induced an increase in ICP, which was attenuated by TEA and iberiotoxin but not by GLB. In an organ bath experiment, Abd Elmoneim et&#xa0;al. (<xref ref-type="bibr" rid="B41">41</xref>) treated rat CC tissues with TEA, GLB, 4-aminopyridine (4-AP, a Kv channel inhibitor), and barium chloride (BaCl2, a Kir channel inhibitor) to examine their effects on relaxation induced by L-Cys (1 &#x3bc;M&#x2013;10 mM). The results showed that TEA and 4-AP remarkably attenuated relaxation, with the effects of TEA being stronger than those of 4-AP, whereas GLB and BaCl2 failed to reduce relaxation. These findings indicate that BKCa and Kv channels are involved in the H<sub>2</sub>S-induced relaxation of rat CC, whereas Kir and K<sub>ATP</sub> channels may not participate in the process. In another study, GLB was found to attenuate the relaxation effects of NaHS on HCC strips (<xref ref-type="bibr" rid="B23">23</xref>); however, the dose of GLB used was 150 &#x3bc;M. When administered at a dose of &gt;10 &#x3bc;M, GLB inhibits the Na<sup>+</sup>&#x2013;K<sup>+</sup> pump and L-type Ca<sup>2+</sup> channel (<xref ref-type="bibr" rid="B64">64</xref>), which may interfere with the results. Consistently, studies have shown that treatment with GLB (10 &#x3bc;M) and NaHS does not suppress relaxation in rat (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B41">41</xref>) or human (<xref ref-type="bibr" rid="B61">61</xref>) cavernosal tissue strips.</p>
<p>RhoA is a monomeric GTP enzyme that is activated upon binding to GTP, subsequently stimulating ROCK (a serine/threonine kinase) (<xref ref-type="bibr" rid="B65">65</xref>). ROCK phosphorylates the myosin-binding subunit of myosin light chain (MLC) phosphatase, which is responsible for the dephosphorylation of MLC, to inactivate the enzyme (<xref ref-type="bibr" rid="B66">66</xref>). In addition, it directly phosphorylates MLC, causing myosin to bind to &#x3b2;-actin, which promotes smooth muscle contraction (<xref ref-type="bibr" rid="B67">67</xref>). Chitaley et&#xa0;al. (<xref ref-type="bibr" rid="B68">68</xref>) used (<italic>R</italic>)-(+)-<italic>trans</italic>-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide (Y-27632, a specific ROCK inhibitor) to examine the effects of ROCK on the cavernosal tone in rats. They found that inhibition of ROCK induced an increase in ICP, which stimulated penile erection in rats. This effect was found to be independent of the NO pathway. d&#x2019;Emmanuele et&#xa0;al. (<xref ref-type="bibr" rid="B23">23</xref>) found that the relaxation effects of NaHS (1 &#x3bc;M&#x2013;10 mM) were considerably stronger in HCC strips precontracted with U46619 or human endothelin-1 (two ROCK pathway modulators) that in those precontracted with phenylephrine (PE). This finding indicates that H<sub>2</sub>S regulates the ROCK pathway. Consistently, another study showed that fasudil (a ROCK inhibitor) reduced the relaxation response of mouse CC to exogenous H<sub>2</sub>S, suggesting that an interaction between H<sub>2</sub>S and ROCK is highly likely (<xref ref-type="bibr" rid="B69">69</xref>). Aydinoglu et&#xa0;al. (<xref ref-type="bibr" rid="B40">40</xref>) were the first to report that ROCK participates in the relaxation-inducing effects of H<sub>2</sub>S in mouse CC contracted with PE. They found that pre-treatment with Y-27632 remarkably reduced cavernosal muscle contraction induced by the PE-driven phosphorylation of the myosin phosphatase-targeting subunit 1 (MYPT1) at Thr696. However, PE-induced muscle contraction almost disappeared in the presence of L-Cys or NaHS. Correspondingly, the combination of Y-27632 and L-Cys (10 mM) or NaHS (1 mM) inhibited the expression of phosphorylated MYPT1, whereas PAG and AOAA reversed this change. Furthermore, Y-27632 increased the basal and L-Cys-induced production of H<sub>2</sub>S, which was attenuated by PAG and AOAA. These findings indicate that ROCK at least partly inhibits CSE/CBS in CCSMCs. In addition to regulating the phosphorylation of MLC, the RhoA/ROCK signaling pathway affects the phenotypic modulation of CCSMCs by regulating the downstream factors CDK2, Cyclin E<sub>1</sub>, and P27<sup>kip1</sup>, thereby promoting smooth muscle contraction (<xref ref-type="bibr" rid="B44">44</xref>). A study showed that NaHS (100 &#x3bc;mol/kg) inhibited the phenotypic transformation of CCSMCs induced by the upregulation of RhoA/ROCK signaling, thereby improving erectile function in rat models of bilateral cavernous nerve injury (BCNI) (<xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>In addition to playing an important role in the abovementioned contraction mechanisms, H<sub>2</sub>S may be involved in other less investigated pathways of CC relaxation, such as the CO/heme oxygenase-1 (HO-1) pathway (<xref ref-type="bibr" rid="B43">43</xref>). Notably, the H<sub>2</sub>S donor used in a majority of the abovementioned studies is NaHS, whose H<sub>2</sub>S release rate may not be sufficient to accurately mimic endogenous H<sub>2</sub>S production. As a slow-H<sub>2</sub>S-releasing donor, GYY4137 is more suitable for investigating the effects of H<sub>2</sub>S on physiological and pathological processes. Qabazard et&#xa0;al. (<xref ref-type="bibr" rid="B45">45</xref>) found that the effects of GYY4137 on the relaxation of rat CC were at least partly mediated by the NO pathway and K<sub>ATP</sub> channel. However, only a few studies have reported the use of GYY4137 to treat penile tissues. Moreover, GYY4137 produces CO, a by-product that acts in a similar way to H<sub>2</sub>S (<xref ref-type="bibr" rid="B70">70</xref>). Therefore, more experimental data are required to support the conclusion of existing studies. An in-depth understanding of the mechanisms through which H<sub>2</sub>S regulates penile erection may guide the development of novel therapeutic approaches for ED.</p>
</sec>
<sec id="s3_1_2">
<label>3.1.2</label>
<title>Therapeutic targets and future perspectives to treat ED</title>
<p>Penile erection involves the cooperation of nerves, blood vessels, and smooth muscle; consequently, lesions or damage in any part of these nerves, blood vessels, and smooth muscle may lead to ED. Neurovascular damage, diabetes, hypertension, side effects of drugs, and testosterone deficiency have been identified as causes of ED (<xref ref-type="bibr" rid="B71">71</xref>). PDE-5 inhibitors (PDE-5is) (such as sildenafil and tadalafil) are considered the first-line treatment for ED (<xref ref-type="bibr" rid="B72">72</xref>); however, some patients have poor outcomes. Before the erection-promoting effects of H<sub>2</sub>S were reported, a novel target, &#x3b2;3-adrenergic receptor, was identified. &#x3b2;3-adrenergic receptors are present in human CCSMCs and cause smooth muscle relaxation in HCC in a cGMP-dependent but NO-independent manner upon activation (<xref ref-type="bibr" rid="B73">73</xref>). Mitidieri et&#xa0;al. (<xref ref-type="bibr" rid="B74">74</xref>) found that activation of &#x3b2;3 receptors by BRL37344 (a &#x3b2;3-selective agonist) relaxed HCC and penile arterial rings in an H<sub>2</sub>S/cGMP-dependent manner, whereas inhibition of CSE notably reduced the relaxation. Treatment with BRL37344 considerably increased H<sub>2</sub>S production, whereas inhibition of CSE reduced the BRL37344-induced increase in cGMP expression in both tissues. Given that their function is independent of the endothelium, selective &#x3b2;3 agonists, such as mirabegron (<xref ref-type="bibr" rid="B75">75</xref>), may serve as alternative treatment agents for patients who do not respond to PDE-5is.</p>
<p>ED has been associated with defects in the L-Cys/H<sub>2</sub>S pathway (<xref ref-type="bibr" rid="B76">76</xref>). The levels of H<sub>2</sub>S synthases are decreased to varying degrees in the penile tissues of rats with ED caused by radical prostatectomy, hyperlipidemia, diabetes, or hypertension (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B77">77</xref>). This phenomenon suggests that ED can be treated with exogenous H<sub>2</sub>S supplementation. The first drug developed was H<sub>2</sub>S-donating derivative of sildenafil (ACS6) (<xref ref-type="bibr" rid="B78">78</xref>). Although the muscle relaxation effects of ACS6 are similar to those of sildenafil citrate at the same concentration, ACS6 is more effective than sildenafil and NaHS in reducing superoxide formation and PDE5 expression. Theoretically, long-term use of ACS6 may improve ED by inhibiting oxidative stress and downregulating PDE5. Several natural plant extracts have been found to stimulate H<sub>2</sub>S synthesis <italic>in vivo</italic>. For example, resveratrol (RVT) (<xref ref-type="bibr" rid="B79">79</xref>), found in red wine, causes CC relaxation in a concentration-dependent manner in mice. This effect can be reversed by CBS inhibitors but not by L-NAME. Although RVT increases the basal and L-Cys-induced production of H<sub>2</sub>S, it does not affect NaHS-induced relaxation. These results suggest that RVT-induced relaxation is at least partly dependent on H<sub>2</sub>S production, does not interfere with the downstream mechanisms of H<sub>2</sub>S production, and is independent of NO. Sodium tanshinone IIA sulfonate (STS) (<xref ref-type="bibr" rid="B77">77</xref>), a water-soluble derivative of lipophilic diterpene isolated from the roots of Danshen plants, can reverse the high fat diet-induced decrease in CBS and CSE expression and H<sub>2</sub>S production in rats. In addition, it can preserve erectile function by activating the Nrf2/HO-1 pathway against high fat diet-induced oxidative stress.</p>
<p>Because H<sub>2</sub>S is primarily released by SMCs instead of endothelial cells, it may serve as a promising therapeutic target in patients with ED with endothelial dysfunction, such as those with metabolic syndrome and diabetes. A study showed that high-fructose diet-induced metabolic syndrome led to a reduction in the basal and L-Cys-induced production of H<sub>2</sub>S in rat penile tissues (<xref ref-type="bibr" rid="B80">80</xref>), whereas supplementation with exogenous H<sub>2</sub>S improved erectile function. GYY4137, an H<sub>2</sub>S donor with sustained release, has been shown to improve cavernosal vascular reactivity by inhibiting the TGF-&#x3b2;1/Smad/CTGF pathway in rats with STZ-induced diabetes (<xref ref-type="bibr" rid="B46">46</xref>). In addition, long-term treatment with GYY4137 can prevent or attenuate the reduction of H<sub>2</sub>S levels and improve cavernosal H<sub>2</sub>S production in diabetes (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). The combination of H<sub>2</sub>S donors and PDE-5is holds great promise in the treatment of ED. A study showed that NaHS combined with tadalafil was more effective than NaHS alone in the treatment of ED in rats with partial bladder outlet obstruction (<xref ref-type="bibr" rid="B81">81</xref>). The reduced erectile response and H<sub>2</sub>S levels were only partially restored upon treatment with NaHS but completely restored upon treatment with both NaHS and tadalafil. In addition, the combined use of NaHS and tadalafil reversed the morphological and functional changes in the penis caused by ischemia after obstruction and had a positive effect on the erectile response. These results suggest that H<sub>2</sub>S can improve ED and restore spontaneous erection with long-term use.</p>
</sec>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Effects of H<sub>2</sub>S on the prostate</title>
<p>PCa, and particularly castration-resistant prostate cancer (CRPC), is the primary focus of research on H<sub>2</sub>S&#x2019; utilities on the prostate. Because the growing and progression of the prostate depend on androgens, androgen deprivation therapy is the mainstay of treatment for advanced PCa. However, most patients inevitably progress to androgen-independent castration resistance, which is a leading cause of death in patients with PCa (<xref ref-type="bibr" rid="B82">82</xref>). Given that the signals generated upon the biding of the androgen receptor (AR) to testosterone or 5&#x3b1;-dihydrotestosterone are closely related to the progression of PCa to CRPC, direct inhibition of AR is one of the widely used therapeutic strategies for PCa (<xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>). The highly conserved DNA-binding domain, one of the four domains of AR, contains two cysteine type 4 zinc fingers; of which, the second zinc finger is the binding site for homodimerization (<xref ref-type="bibr" rid="B83">83</xref>). According to Zhao et&#xa0;al. (<xref ref-type="bibr" rid="B30">30</xref>), H<sub>2</sub>S suppresses transactivation of AR by S-sulfhydrating cysteine Cys611 and Cys614 sites of its second zinc finger, thereby inhibiting the progression of antiandrogen-resistant PCa cells. Bicalutamide competes with AR for binding, making it an effective cancer treatment. It has been reported that PCa (LNCAP-B) cells resistant to bicalutamide expressed less of CSE than PCa (LNCaP) cells dependent on androgens. LNCaP-B cells overexpressing CSE or administered NaHS re-established sensitivity to bicalutamide, while CSE-deficient LNCaP cells persist in growing with the utilization of bicalutamide. On the contrary, changes in CBS expression under the same conditions did not have obvious effects on drug resistance. Therefore, it is possible to use the CSE/H<sub>2</sub>S system to assess prognosis and to treat early PCa and CRPC. However, Fukami et&#xa0;al. (<xref ref-type="bibr" rid="B47">47</xref>) showed that the effects of H<sub>2</sub>S were not beneficial to the treatment of PCa. They showed that androgen deprivation-induced enhancement of cytosolic cAMP elevated CSE expression and H<sub>2</sub>S production. A subsequent study found that H<sub>2</sub>S enhanced the activity of Cav3.2, which led to an increase in proliferation of tumors independent of androgen. Neuroendocrine phenotypes account for approximately 20&#x2013;25% of all metastatic CRPC cases. In most cases, neuroendocrine differentiation is induced by androgen deprivation therapy (<xref ref-type="bibr" rid="B84">84</xref>). Differentiation of LNCaP cells is characterized by the upregulation of Ca<sup>2+</sup>-dependent secretion of mitogenic factors and the overexpression of Ca<sub>v</sub>3.2 T-type Ca<sup>2+</sup> channels that contribute to their secretion (<xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B86">86</xref>). Fukami et&#xa0;al. showed that differentiated cells had increased expression of CSE and CBS and elevated T-type Ca<sup>2+</sup> channel-dependent currents (T-currents). The T-currents were suppressed by CSE inhibitors but not by CBS inhibitors and were enhanced by H<sub>2</sub>S donors (NaHS, 0.1&#x2013;1.5 mM; Na<sub>2</sub>S, 0.03&#x2013;0.1 mM). These results indicate that in LNCaP cells undergoing neuroendocrine differentiation, H<sub>2</sub>S is able to stimulate T-type Ca<sup>2+</sup> channels, leading to the development of neuroendocrine CRPC.</p>
<p>The abovementioned studies indicate that CSE/H<sub>2</sub>S is associated with the progression of PCa, and the contradictory conclusions could be attributed to the fact that PCa cells respond differently to H<sub>2</sub>S depending on their source, and dose and type of H<sub>2</sub>S donor (<xref ref-type="bibr" rid="B87">87</xref>). Research shows that drugs related to H<sub>2</sub>S are effective in treating cancer. Multi-cancer cell lines, including PCa cells, are inhibited 28&#x2013;3000 times more effectively by H<sub>2</sub>S-releasing non-steroidal anti-inflammatory drugs (HS-NSAIDs) than by those of conventional NSAIDs (<xref ref-type="bibr" rid="B88">88</xref>). HS-ibuprofen is 200 times more potent than ibuprofen in LNCaP cells owing to its covalent attachment to the H<sub>2</sub>S-releasing moiety. The H<sub>2</sub>S moiety of H<sub>2</sub>S-releasing doxorubicin (H<sub>2</sub>SDox) exerts cardioprotective effects, reducing the cardiovascular side effects of doxorubicin (<xref ref-type="bibr" rid="B89">89</xref>). By releasing the SH2 group, disulfide bonds formation on P-gp would disrupt P-gp activity, ultimately improving tumor sensitivity to doxorubicin. A study showed that intracellular drug accumulation was substantially higher after H<sub>2</sub>SDox treatment than after doxorubicin treatment in DU-145 PCa cells resistant to androgen and doxorubicin. Zhou et&#xa0;al. (<xref ref-type="bibr" rid="B90">90</xref>) combined H<sub>2</sub>S with classical drugs and used nanotechnology to develop Zn<sup>2+</sup>-interference and H<sub>2</sub>S-induced therapeutics, which responds to the tumor microenvironment (TME) and is derived from tannic acid (TA)-altered zinc sulfide nanoparticles (ZnS@TA). ZnS@TA nanoparticles responded specifically to tumor cells based on the pH. H<sub>2</sub>S and Zn<sup>2+</sup> were released in a small amount in a neutral environment (pH = 7.4) but had good degradation performance in a simulated TME. Consistently, ZnS@TA nanoparticles had no obvious effects on the viability of DU-145 cells under neutral conditions but considerably decreased cell viability in the TME at the same concentration. ZnS@TA nanoparticles attenuated the migratory and invasive abilities of PCa cells by increasing intracellular TA and Zn<sup>2+</sup> levels. Subsequently, Zn<sup>2+</sup> ions and H<sub>2</sub>S synergistically enhanced tumor cell apoptosis.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Effects of H<sub>2</sub>S on the testis</title>
<p>As a gaseous air pollutant, H<sub>2</sub>S may impair spermatogenesis (<xref ref-type="bibr" rid="B91">91</xref>) and inhibit sperm mobility via mechanisms related to AMPK/Akt (<xref ref-type="bibr" rid="B48">48</xref>) when combined with NH<sub>3</sub>, thereby disrupting male fertility. However, there are several investigations indicate that H<sub>2</sub>S can protect the testis and germ cells by inhibiting inflammation, oxidant activity, and apoptosis (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). The testis and sperm are highly susceptible to oxidative stress-induced damage. Studies have shown that physical stimulation (heat stress and restraint stress) (<xref ref-type="bibr" rid="B92">92</xref>), ischemia&#x2013;reperfusion (I/R) injury, varicocele (testicular torsion), and ingestion of reproductive-toxic substances (cisplatin and nanoplastics) can increase the production of reactive oxygen species (ROS) in the testis, leading to testicular dysfunction and germ cell apoptosis. In addition, the aforementioned conditions may decrease the expression of CBS and CSE and production of H<sub>2</sub>S in the testis. Therefore, low levels of H<sub>2</sub>S in the testis may play a key role in male infertility.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Protective effects of H<sub>2</sub>S on the testis and germ cells. Apaf-1, apoptosis protease-activating factor-1; HO-1, heme oxygenase-1; NQO1, NADPH dehydrogenase quinone 1.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1377090-g002.tif"/>
</fig>
<p>Li et&#xa0;al. (<xref ref-type="bibr" rid="B32">32</xref>) stimulated the testis of mice with heat exposure (42&#xb0;C, 30 minutes/day, 3 days) and found that heat stress remarkably elevated ROS generation and inhibited the SOD activity in germ cells. However, exogenous administration of NaHS stimulated SOD activity and reduced ROS generation. Mechanistically, H<sub>2</sub>S can inhibit cytochrome C release and Bax/Bcl-2 ratio, thus impeding the heat stress-induced testicular germ cells apoptosis. Bozkurt et&#xa0;al. (<xref ref-type="bibr" rid="B49">49</xref>) found that H<sub>2</sub>S alleviated excessive tissue detriment by reducing the levels of iNOS and the inflammatory cytokine TNF-&#x3b1; in a rat model of testicular torsion-induced I/R damage. Furthermore, H<sub>2</sub>S suppressed apoptosis through reducing apoptosis protease activating factor-1 level, thus protecting against testicular damage. Patients with varicocele are usually treated with surgery; however, the removal of the varicose veins (varicocelectomy) carries not only the risk of surgery but also the risk of postoperative side effects, including recurrence, hydrocele formation, atrophy, and bleeding (<xref ref-type="bibr" rid="B93">93</xref>). Rats with left varicocele exhibited significant reductions in left testicle and epididymis weights, as well as diameters and epithelial thicknesses of the seminiferous tubules. When NaHS was administered over a long period, it reduced oxidative stress and apoptosis in the testicles, restoring above results (<xref ref-type="bibr" rid="B94">94</xref>). According to the study by Xia et&#xa0;al. (<xref ref-type="bibr" rid="B54">54</xref>), GYY4137 had beneficial effects on rats with varicocele-induced ipsilateral epididymis damage and sperm injury through stimulating PI3K/Akt signaling. Additionally, Shafie et&#xa0;al. (<xref ref-type="bibr" rid="B95">95</xref>) reported that testosterone combined with NaHS alleviated varicocele-induced injury in rats. It was shorter in duration and required lower doses than using NaHS for a long period of time when testosterone was combined with NaHS.</p>
<p>Cisplatin (CIS), an antineoplastic drug increases the levels of free radicals and decreases those of antioxidant enzymes or non-enzymes in testicular tissue via oxidative stress, resulting in testicular toxicity (<xref ref-type="bibr" rid="B96">96</xref>). It was observed in rats testicular tissues that administration with CIS notably elevated the content of MDA, a direct indicator of ROS-induced lipid peroxidation, and inhibited the activity of SOD (<xref ref-type="bibr" rid="B97">97</xref>). Whereas, CIS-induced changes in biochemistry, histology, and morphology could be effectively reversed with NaHS treatment. Ingested polystyrene nanoparticles can accumulate in the testis and cause testicular atrophy, degeneration of spermatogenic tubules, and spermatogenesis disorders (<xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B99">99</xref>). Using mouse spermatocytes, Li et&#xa0;al. (<xref ref-type="bibr" rid="B50">50</xref>) observed that nanoplastics caused autophagy and apoptosis dependent on ROS, leading to reproductive noxiousness. Conversely, H<sub>2</sub>S mitigated nanoplastic-mediated reproductive noxiousness via upregulating antioxidant enzymes level, including HO-1 and NQO1, through the Keap1/Nrf2 pathway. Additionally, testosterone inadequacy may adversely impact sperm morphology and vitality, potentially compromising male fertility (<xref ref-type="bibr" rid="B100">100</xref>). A mouse Leydig tumor cell line with H<sub>2</sub>O<sub>2</sub> + LPS-induced testosterone deficits was overexpressed of CBS to restore testosterone levels by S-sulfhydrylating PDE4A and PDE8A and stimulating the cAMP/PKA signaling (<xref ref-type="bibr" rid="B51">51</xref>). Another study showed that animal models of deficient H<sub>2</sub>S production had lowered sperm vitality, which was alleviated upon exogenously administering H<sub>2</sub>S or overexpressing CBS (<xref ref-type="bibr" rid="B52">52</xref>). The stress-induced decrease in endogenous H<sub>2</sub>S generation was involved in damaged spermatogenesis and a defective blood&#x2013;testis barrier.</p>
<p>It is possible that H<sub>2</sub>S may enhance sperm vitality <italic>in vitro</italic>, which could have implications for assisted reproduction. During the extraction of human sperm from a sperm bank for artificial insemination, freezing and thawing can produce ROS, resulting in oxidative stress-induced impairment to sperm (<xref ref-type="bibr" rid="B101">101</xref>). H<sub>2</sub>S donors are capable of maintaining sperm vitality, reducing acrosomal deprivation, and protecting sperm against oxidative stress (<xref ref-type="bibr" rid="B53">53</xref>). In particular, a high concentration of H<sub>2</sub>S attenuates sperm movement (<xref ref-type="bibr" rid="B102">102</xref>). In contrast, the simultaneous administration of low concentrations of H<sub>2</sub>S and NO donors has been shown to promote sperm frontward movement and safeguard plasma membrane against oxidative stress (<xref ref-type="bibr" rid="B103">103</xref>). According to Pintus et&#xa0;al. (<xref ref-type="bibr" rid="B104">104</xref>), short-term treatment with two N-thiocarboxyanhydrides derived from glycine and leucine enhanced the mitochondrial activity of pig sperm cells even in the presence of ROS. The two amino acid-based H<sub>2</sub>S-releasing drugs can mimic the physiological H<sub>2</sub>S release when carbonic anhydrase is present without causing cellular harm. Additionally, they can enhance sperm vitality after short-term treatments, consequently prolonging sperm survival.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Effects of H<sub>2</sub>S on other male reproductive organs</title>
<p>Studies investigating the effects of H<sub>2</sub>S on the epididymis and VD are limited. The contraction of the epididymis and VD contributes to the discharge of sperm. Studies have shown that the L-Cys/H<sub>2</sub>S pathway is involved in the regulation of VD tonic contractions and that H<sub>2</sub>S relaxes VD smooth muscle in a concentration-dependent manner (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B55">55</xref>). Based on these findings, the mechanisms underlying VD relaxation have been investigated in some studies. Li et&#xa0;al. (<xref ref-type="bibr" rid="B55">55</xref>) treated VD bands with 2-APB, an inhibitor of transient receptor potential [TRP] channels, and apamin, an inhibitor of Ca<sup>2+</sup>-activated K<sup>+</sup> [SKCa] channels, as well as L-NAME, TEA, iberiotoxin, GLB, and subsequently treated them with NaHS. According to the results, L-NAME, GLB, 2-APB, and apamin had no influence on the relaxation of VD to NaHS, while TEA and iberiotoxin considerably reduced it. These findings indicate that H<sub>2</sub>S may target BKCa channels in VD. Moreover, N-ethylmaleimide safeguards thiols against oxidation by alkylation, counteracting NaHS-mediated smooth muscle relaxation in VD; however, the strong reducing agent DTT, which can disrupt disulfide bonds in proteins, did not alter the effect of NaHS. The results indicate that H<sub>2</sub>S may impact the function of BKCa channels in VD smooth muscle by S-sulfhydration, consequently leading to muscle relaxation. In the aforementioned study, NaHS was used at a concentration of 1 mM, which exceeds the physiological concentration of H<sub>2</sub>S. Therefore, whether H<sub>2</sub>S regulates spontaneous contractions in VD in the physiological state remains unknown. In the epididymal lumen, the microenvironment supports sperm vitality, and mature sperm are stocked in the epididymis&#x2019; tail until ejaculation (<xref ref-type="bibr" rid="B105">105</xref>). Gao et&#xa0;al. (<xref ref-type="bibr" rid="B34">34</xref>) found that H<sub>2</sub>S induced remarkable K<sup>+</sup> release from the epididymal epithelium in rats through stimulating K<sub>ATP</sub> and BKCa channels. An increase in K<sup>+</sup> concentration in the cauda epididymal intraluminal fluid inhibited sperm vitality regardless of pH. Consequently, H<sub>2</sub>S created a microenvironment with an elevated K<sup>+</sup> concentration in the cauda epididymis lumen, which maintained epididymal sperm quiescence prior to ejaculation. According to these findings, H<sub>2</sub>S plays a significant role in ejaculation. It is possible that future studies will lead to the development of novel strategies for treating asthenospermia, spermatorrhea, as well as premature ejaculation.</p>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>Effects of H<sub>2</sub>S on other organs in the genitourinary system</title>
<p>In addition to the aforementioned components of the male reproductive system, the kidneys, ureters, bladder, and urethra are also impacted by H<sub>2</sub>S. Among these, the kidneys have been the subject of extensive research, particularly in relation to acute kidney injury, chronic kidney disease, kidney cancer, and other related conditions. Despite this, the bladder is often the primary organ considered in discussions of the genitourinary system due to its close association with the reproductive system. Specifically, the correlation between ED and lower urinary tract symptoms (LUTS) has been a topic of widespread examination.</p>
<p>H<sub>2</sub>S has been shown to potentially alleviate LUTS and associated ED by inducing relaxation of the smooth muscle in the bladder. Male LUTS encompasses a range of structural, functional, and sensory abnormalities affecting the lower urinary tract, including pelvic and pelvic floor organs such as the bladder, prostate, and urethra (<xref ref-type="bibr" rid="B106">106</xref>). The presentation of LUTS is multifaceted, with symptoms categorized into storage, voiding, and post-voiding symptoms, often occurring concurrently in affected individuals (<xref ref-type="bibr" rid="B107">107</xref>). The correlation between ED and LUTS has been extensively studied in recent years, with a growing body of evidence indicating a strong link, particularly in men with LUTS who are at a higher risk of developing ED (<xref ref-type="bibr" rid="B108">108</xref>, <xref ref-type="bibr" rid="B109">109</xref>). For instance, a comprehensive population-based study examining the impact of overactive bladder, specifically urgency as a storage symptom, on male sexual health revealed a significant association with ED (<xref ref-type="bibr" rid="B110">110</xref>).</p>
<p>The primary mechanism of action for current first-line medications used in the treatment of LUTS involves the relaxation of bladder smooth muscle (<xref ref-type="bibr" rid="B111">111</xref>). The process of bladder contraction during urination is primarily regulated by cholinergic, adrenergic, and sensorimotor nerves (<xref ref-type="bibr" rid="B112">112</xref>). Early research indicated that the effect of H<sub>2</sub>S on the bladder mirrors that of capsaicin. In rats, NaHS prompted bladder contractions by stimulating primary afferent nerve (sensory nerve) terminals to release tachykinin, which subsequently activated NK1 and NK2 receptors (<xref ref-type="bibr" rid="B113">113</xref>). It is noteworthy that sensory nerves rapidly developed desensitization to H<sub>2</sub>S, leading to the cessation of contractions. Additionally, the application of H<sub>2</sub>S to desensitized sensory nerves resulted in the release of inhibitory neuropeptides and induced bladder relaxation (<xref ref-type="bibr" rid="B114">114</xref>). As the research progressed, Fernandes et&#xa0;al. (<xref ref-type="bibr" rid="B115">115</xref>) determined that GYY4137 activates L-type Cav channels in a concentration-dependent manner to enhance ACh release from guinea pig bladder neurons, thereby increasing the amplitude of phasic contraction of bladder smooth muscle. These experiments utilized isolated bladder strips with the urothelium removed, despite the presence of H<sub>2</sub>S not only in the nerve fiber and smooth muscle layers of the bladder but also in the&#xa0;urothelium (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B116">116</xref>, <xref ref-type="bibr" rid="B117">117</xref>). Consistently, activation of M1/M3 receptors in the human urothelium leads to the phosphorylation of CBS at Ser227 through the cGMP/PKG pathway, resulting in elevated epithelial H<sub>2</sub>S production and bladder band relaxation (<xref ref-type="bibr" rid="B118">118</xref>). The excision of the urothelium and the use of CBS inhibitors both markedly enhanced carbachol-induced contractions in human bladder strips. Additionally, activation of &#x3b2;3 receptors in the human urothelium has been shown to stimulate H<sub>2</sub>S production and promote bladder relaxation. CSE, but not the CBS inhibitor, was found to increase BRL37344-induced relaxation, a response that was abolished following epithelial removal (<xref ref-type="bibr" rid="B117">117</xref>). These findings suggest that H<sub>2</sub>S may play a role in modulating bladder function as a neuromodulator.</p>
<p>In addition, H<sub>2</sub>S also causes relaxation of bladder smooth muscle by activating ion channels. It is now generally confirmed that H<sub>2</sub>S induces bladder relaxation by activating K<sub>ATP</sub> channels and mechanisms that desensitize Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B114">114</xref>, <xref ref-type="bibr" rid="B119">119</xref>). On the contrary, the BKCa channel, another frequently researched ion channel, has sparked controversy. Fernandes et&#xa0;al. (<xref ref-type="bibr" rid="B115">115</xref>) demonstrated that GYY4137 directly inhibited BKCa channels activity and decreased BK channels open probability in guinea pig bladder smooth muscle, leading to an increase in spontaneous phasic and neurally evoked contractions. Conversely, inhibiting BKCa channels in pig bladder neck smooth muscle has been found to diminish the relaxant effects of rolipram, a PDE4 inhibitor, with the observed impact of rolipram being partially attributed to H<sub>2</sub>S released from neurons. Essentially, the relaxation of pig bladder neck smooth muscle may be facilitated by H<sub>2</sub>S activation of BKCa channels (<xref ref-type="bibr" rid="B119">119</xref>). The conflicting outcomes of the two studies underscore the necessity for additional research, particularly considering the absence of urothelium in the bladder tissues utilized. Factors such as species specificity and the quality of experimental reagents must also be taken into account. Recent advancements in the field have identified PDE inhibitors as promising therapeutic options for the management of LUTS and ED (<xref ref-type="bibr" rid="B120">120</xref>). Numerous investigations have demonstrated the involvement of H<sub>2</sub>S in the mechanism of action of these drugs, with rolipram exhibiting significantly greater efficacy compared to sildenafil (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B121">121</xref>, <xref ref-type="bibr" rid="B122">122</xref>).</p>
<p>In conclusion, the relaxation effect of H<sub>2</sub>S on bladder smooth muscle is beneficial to relieve LUTS inclusive of overactive bladder, thereby removing the primary cause of related ED and improving the life quality of patients in many ways.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>H<sub>2</sub>S, the third gas signaling molecule after NO and CO, is involved in various pathophysiological processes in the male reproductive system. In particular, it promotes penile erectile function, protects testicular function, inhibits the progression of PCa, regulates the spontaneous contraction of VD, and maintains the hypomotility of sperm in the cauda epididymis before ejaculation. A complex mechanism by which H<sub>2</sub>S relaxes smooth muscles in the penis may involve activating BKCa and Kv channels, inhibiting RhoA/ROCK signaling pathways, and raising cGMP levels to bypass NO pathway. Recently, selective &#x3b2;3 agonists such as mirabegron (<xref ref-type="bibr" rid="B75">75</xref>) and natural extracts such as RVT (<xref ref-type="bibr" rid="B79">79</xref>) and STS (<xref ref-type="bibr" rid="B77">77</xref>) have been shown to improve ED, with both classes of compounds being at least partly dependent on H<sub>2</sub>S. Besides, the relaxation of bladder smooth muscle by H<sub>2</sub>S has been shown to improve LUTS and subsequent ED. Consequently, the multifaceted therapeutic benefits of H<sub>2</sub>S offer potential for reducing medication dosages and enhancing the quality of life for patients with both conditions. Therefore, H<sub>2</sub>S is a promising target for the clinical treatment of male reproductive system diseases.</p>
<p>The process of H<sub>2</sub>S promoting penile erection may involve a variety of mechanisms, however, a unanimous final conclusion has not yet been reached. There is a very interesting theory in the literature on ACS6 treatment of ED (<xref ref-type="bibr" rid="B78">78</xref>) and this theory (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>) is as follows: Superoxides derived from NADPH oxidase (NOX) react with NO to form active nitrogen in CCSMCs and arterial SMCs, thereby reducing the bioavailability of NO and attenuating penile erection (<xref ref-type="bibr" rid="B123">123</xref>&#x2013;<xref ref-type="bibr" rid="B126">126</xref>). NO inhibits the activity and expression of NOX via the cGMP/PKG pathway (<xref ref-type="bibr" rid="B127">127</xref>&#x2013;<xref ref-type="bibr" rid="B129">129</xref>). However, in patients with ED with diseases that impair endothelial function, such as diabetes, decreased NO levels lead to a reduction in cGMP expression, which in turn attenuates the inhibitory effects of NO on NOX and increases the production of superoxides, eventually forming a vicious circle. These superoxides upregulate PDE5 expression, resulting in the increased metabolism of cGMP. Similar to NO, H<sub>2</sub>S inhibits the activity and expression of NOX via the cAMP/PKA pathway (<xref ref-type="bibr" rid="B130">130</xref>). NaHS can activate PKG dependent on cGMP (<xref ref-type="bibr" rid="B131">131</xref>). In addition, the superoxides derived from NOX can activate ROCK (<xref ref-type="bibr" rid="B132">132</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Regulatory effects of H<sub>2</sub>S on erectile dysfunction. ROCK, Rho-kinase; sGC, soluble guanylate cyclase; MYPT1, myosin phosphatase-targeting subunit 1; cGMP, cyclic guanosine monophosphate.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1377090-g003.tif"/>
</fig>
<p>Although the abovementioned theory has not been comprehensively investigated, we speculate that &#x201c;inhibition of superoxide production&#x201d; is a more reasonable explanation for the contradictory results of existing studies. As well as activating PKA and PKG, H<sub>2</sub>S inhibits superoxide generation by regulating Nrf2 and downstream anti-oxidative stress proteins, such as SOD, NQO1, and HO-1, via S-sulfhydration of Keap1 (<xref ref-type="bibr" rid="B133">133</xref>). In addition to activating K<sub>ATP</sub> (<xref ref-type="bibr" rid="B134">134</xref>) and BKCa (<xref ref-type="bibr" rid="B55">55</xref>) channels, H<sub>2</sub>S-mediated S-sulfhydration effect reduces PDE5A dimerization (<xref ref-type="bibr" rid="B135">135</xref>). Therefore, irrespective of the type of pathway inhibitors used, they can only partially prevent the relaxation induced by H<sub>2</sub>S.</p>
<p>Although exogenous H<sub>2</sub>S has been shown to alleviate ED, further investigation into the mechanisms through which H<sub>2</sub>S promotes erectile function may guide the development of targeted drugs. Moreover, the role of endogenous H<sub>2</sub>S in promoting penile erection remains uncertain. Ghasemi et&#xa0;al. (<xref ref-type="bibr" rid="B26">26</xref>) found that PAG increased NANC relaxation in rat CC, which may be attributed to the inhibition of NOS activity by H<sub>2</sub>S or the direct chemical reaction of H<sub>2</sub>S with endogenous nitrogen oxides, such as NO, NO<sup>+</sup>, and HNO. Based on this hypothesis, the authors divided rat CC strips precontracted with PE into three groups, which were treated with S-nitrosoglutathione, SNP, and Angeli&#x2019;s salt (three nitrogen oxide donors), respectively. Subsequently, each group was treated with NaHS at doses of 30 nM, 300 nM, or 30 &#x3bc;M. The results showed that all three nitrogen oxide donors induced the relaxation of rat CC tissues in a concentration-dependent manner; however, treatment with NaHS remarkably inhibited the effects of Angeli&#x2019;s salt. These findings indicate that NO participates in the regulation of erectile function mainly in the form of HNO and is inhibited by H<sub>2</sub>S. Some studies have suggested that the physiological concentration of H<sub>2</sub>S is at the nanomolar level (<xref ref-type="bibr" rid="B136">136</xref>). Ghasemi et&#xa0;al. showed that CC relaxation was observed only after treatment with NaHS. Therefore, endogenous H<sub>2</sub>S may inhibit nitrogenous relaxation in CC. However, to date, limited studies have focused on this topic, and further research is warranted to determine the regulatory effects of endogenous H<sub>2</sub>S on CC relaxation.</p>
<p>In addition to its effects on the penis, H<sub>2</sub>S has diverse effects on other male reproductive organs, which warrant an in-depth investigation. The expression of CBS is not considerably altered in hormone-dependent and drug-resistant human PCa tissues (<xref ref-type="bibr" rid="B30">30</xref>). Even if it is increased after neuroendocrine differentiation of PCa cells, it does not appear to be involved in the effects of H<sub>2</sub>S (<xref ref-type="bibr" rid="B47">47</xref>). However, overexpression of CBS in the testis can alleviate spermatogenesis disorders (<xref ref-type="bibr" rid="B51">51</xref>), and CBS/H<sub>2</sub>S can regulate testosterone synthesis (<xref ref-type="bibr" rid="B100">100</xref>) Therefore, the use of CBS as a therapeutic target for restoring testicular function may minimize the risk of side effects on the prostate. Given that successful ejaculation requires smooth muscle contraction in the VD, seminal vesicle, and prostate (<xref ref-type="bibr" rid="B137">137</xref>), drugs targeting H<sub>2</sub>S in the VD may be used to treat premature ejaculation. However, the effects of H<sub>2</sub>S on the VD suggest that the half-life of H<sub>2</sub>S should be controlled for a certain period to prevent ejaculation disorders and maintain normal sexual function and effective sexual behavior in men. In conclusion, H<sub>2</sub>S possesses great potential in the treatment of male reproductive system diseases.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>YS: Writing &#x2013; original draft. CM: Writing &#x2013; original draft. QZ: Writing &#x2013; original draft. RZ: Writing &#x2013; original draft. DJ: Writing &#x2013; review &amp; editing. XS: Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the China Postdoctoral Science Foundation (2022M711089), Heilongjiang Provincial Natural Science Foundation (YQ 2022H020), Postdoctoral Fund of Heilongjiang Province (LBHZ21080) and (LBHZ19035), Heilongjiang Provincial Health Commission Fund (20210202010178), and Doctor Innovation Fund of Heilongjiang University of Traditional Chinese Medicine (2019BS06).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Bullet Edits Limited for the linguistic editing and proofreading of the manuscript.</p>
</ack>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyaso</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ogawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Itoh</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Microenvironment for spermatogenesis and sperm maturation</article-title>. <source>Histochem Cell Biol</source>. (<year>2022</year>) <volume>157</volume>:<page-range>273&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00418-021-02071-z</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farsimadan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Motamedifar</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Bacterial infection of the male reproductive system causing infertility</article-title>. <source>J Reprod Immunol</source>. (<year>2020</year>) <volume>142</volume>:<fpage>103183</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jri.2020.103183</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fozooni</surname> <given-names>R</given-names>
</name>
<name>
<surname>Jafarzadeh Shirazi</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Saedi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Namavar Jahromi</surname> <given-names>B</given-names>
</name>
<name>
<surname>Khoradmehr</surname> <given-names>A</given-names>
</name>
<name>
<surname>Anvari</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Male subfertility effects of sub-chronic ethanol exposure during stress in a rat model</article-title>. <source>Alcohol</source>. (<year>2021</year>) <volume>96</volume>:<fpage>63</fpage>&#x2013;<lpage>71</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.alcohol.2021.08.003</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Environmental pollutants exposure and male reproductive toxicity: The role of epigenetic modifications</article-title>. <source>Toxicology</source>. (<year>2021</year>) <volume>456</volume>:<fpage>152780</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tox.2021.152780</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>H</given-names>
</name>
<name>
<surname>You</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>miRNA-138&#x2013;5p suppresses cigarette smoke-induced apoptosis in testicular cells by targeting Caspase-3 through the Bcl-2 signaling pathway</article-title>. <source>J Biochem Mol Toxicol</source>. (<year>2021</year>) <volume>35</volume>:<elocation-id>e22783</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jbt.22783</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castela</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>P</given-names>
</name>
<name>
<surname>Domingues</surname> <given-names>VF</given-names>
</name>
<name>
<surname>Pa&#xed;ga</surname> <given-names>P</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>R</given-names>
</name>
<name>
<surname>Vendeira</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of oxidative stress-induced systemic and cavernosal molecular alterations in the progression of diabetic erectile dysfunction</article-title>. <source>J Diabetes</source>. (<year>2015</year>) <volume>7</volume>:<fpage>393</fpage>&#x2013;<lpage>401</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/1753-0407.12181</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalinina</surname> <given-names>EV</given-names>
</name>
<name>
<surname>Gavriliuk</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Pokrovsky</surname> <given-names>VS</given-names>
</name>
</person-group>. <article-title>Oxidative stress and redox-dependent signaling in prostate cancer</article-title>. <source>Biochem (Mosc)</source>. (<year>2022</year>) <volume>87</volume>:<page-range>413&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1134/S0006297922050030</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erfani</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Sadeghi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tavalaee</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tabandeh</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Nasr-Esfahani</surname> <given-names>MH</given-names>
</name>
</person-group>. <article-title>Evaluation of oxidative stress in testis and sperm of rat following induced varicocele</article-title>. <source>Urol. J</source>. (<year>2019</year>) <volume>16</volume>:<page-range>300&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.22037/uj.v0i0.4740</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bisht</surname> <given-names>S</given-names>
</name>
<name>
<surname>Faiq</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tolahunase</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dada</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Oxidative stress and male infertility</article-title>. <source>Nat Rev Urol</source>. (<year>2017</year>) <volume>14</volume>:<page-range>470&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrurol.2017.69</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>The gasotransmitter role of hydrogen sulfide</article-title>. <source>Antioxid Redox Signal</source>. (<year>2003</year>) <volume>5</volume>:<fpage>493</fpage>&#x2013;<lpage>501</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/152308603768295249</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Teng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen sulfide improves endothelial dysfunction by inhibiting the vicious cycle of NLRP3 inflammasome and oxidative stress in spontaneously hypertensive rats</article-title>. <source>J Hypertens</source>. (<year>2019</year>) <volume>37</volume>:<page-range>1633&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/HJH.0000000000002101</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shirazi</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Azarnezhad</surname> <given-names>A</given-names>
</name>
<name>
<surname>Abazari</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Poorebrahim</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ghoraeian</surname> <given-names>P</given-names>
</name>
<name>
<surname>Sanadgol</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>The role of nitric oxide signaling in renoprotective effects of hydrogen sulfide against chronic kidney disease in rats: Involvement of oxidative stress, autophagy and apoptosis</article-title>. <source>J Cell Physiol</source>. (<year>2019</year>) <volume>234</volume>:<page-range>11411&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcp.27797</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Regulatory effects of hydrogen sulfide on the female reproductive system</article-title>. <source>Eur J Pharmacol</source>. (<year>2024</year>) <volume>963</volume>:<fpage>176265</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2023.176265</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#x158;imn&#xe1;&#x10d;ov&#xe1;</surname> <given-names>H</given-names>
</name>
<name>
<surname>Moravec</surname> <given-names>J</given-names>
</name>
<name>
<surname>&#x160;tiavnick&#xe1;</surname> <given-names>M</given-names>
</name>
<name>
<surname>Havr&#xe1;nkov&#xe1;</surname> <given-names>J</given-names>
</name>
<name>
<surname>Monsef</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ho&#x161;ek</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Evidence of endogenously produced hydrogen sulfide (H2S) and persulfidation in male reproduction</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>:<fpage>11426</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-022-15360-x</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>XL</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>XH</given-names>
</name>
</person-group>. <article-title>Hydrogen sulfide protects Sertoli cells against toxicant Acrolein-induced cell injury</article-title>. <source>Food Chem Toxicol</source>. (<year>2023</year>) <volume>176</volume>:<fpage>113784</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fct.2023.113784</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivencia</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Esposito</surname> <given-names>E</given-names>
</name>
<name>
<surname>Brancaleone</surname> <given-names>V</given-names>
</name>
<name>
<surname>Castaldo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cirino</surname> <given-names>G</given-names>
</name>
<name>
<surname>P&#xe9;rez-Vizcaino</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE-/- mice corpus cavernosum microcirculation</article-title>. <source>Pharmacol Res</source>. (<year>2023</year>) <volume>194</volume>:<fpage>106834</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2023.106834</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srilatha</surname> <given-names>B</given-names>
</name>
<name>
<surname>Muthulakshmi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Adaikan</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>PK</given-names>
</name>
</person-group>. <article-title>Endogenous hydrogen sulfide insufficiency as a predictor of sexual dysfunction in aging rats</article-title>. <source>Aging. Male</source>. (<year>2012</year>) <volume>15</volume>:<page-range>153&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/13685538.2012.668722</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamoun</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Endogenous production of hydrogen sulfide in mammals</article-title>. <source>Amino. Acids</source>. (<year>2004</year>) <volume>26</volume>:<page-range>243&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00726-004-0072-x</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Shimizu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shimizu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Higashi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ono</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Possible role of hydrogen sulfide as an endogenous relaxation factor in the rat bladder and prostate</article-title>. <source>Neurourol. Urodyn</source>. (<year>2018</year>) <volume>37</volume>:<page-range>2519&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/nau.23788</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibuya</surname> <given-names>N</given-names>
</name>
<name>
<surname>Koike</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ishigami-Yuasa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kimura</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ogasawara</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells</article-title>. <source>Nat Commun</source>. (<year>2013</year>) <volume>4</volume>:<fpage>1366</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms2371</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener</article-title>. <source>EMBO. J</source>. (<year>2001</year>) <volume>20</volume>:<page-range>6008&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/emboj/20.21.6008</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srilatha</surname> <given-names>B</given-names>
</name>
<name>
<surname>Adaikan</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>PK</given-names>
</name>
</person-group>. <article-title>Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function</article-title>. <source>J Sex Med</source>. (<year>2007</year>) <volume>4</volume>:<page-range>1304&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1743-6109.2007.00561.x</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>d&#x2019;Emmanuele</surname> <given-names>diVBR</given-names>
</name>
<name>
<surname>Sorrentino</surname> <given-names>R</given-names>
</name>
<name>
<surname>Maffia</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mirone</surname> <given-names>V</given-names>
</name>
<name>
<surname>Imbimbo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fusco</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation</article-title>. <source>Proc Natl Acad Sci U. S. A</source>. (<year>2009</year>) <volume>106</volume>:<page-range>4513&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0807974105</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gai</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>HF</given-names>
</name>
<name>
<surname>Du</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Characterization of hydrogen sulfide and its synthases, cystathionine &#x3b2;-synthase and cystathionine &#x3b3;-lyase, in human prostatic tissue and cells</article-title>. <source>Urology</source>. (<year>2012</year>) <volume>79</volume>:<fpage>483.e1</fpage>&#x2013;<lpage>483.e4835</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.urology.2011.10.013</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gai</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Wahafu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>XC</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>YX</given-names>
</name>
<etal/>
</person-group>. <article-title>Further evidence of endogenous hydrogen sulphide as a mediator of relaxation in human and rat bladder</article-title>. <source>Asian. J Androl</source>. (<year>2013</year>) <volume>15</volume>:<page-range>692&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/aja.2013.32</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghasemi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dehpour</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>KP</given-names>
</name>
<name>
<surname>Mani</surname> <given-names>AR</given-names>
</name>
</person-group>. <article-title>Role of endogenous hydrogen sulfide in neurogenic relaxation of rat corpus cavernosum</article-title>. <source>Biochem Pharmacol</source>. (<year>2012</year>) <volume>83</volume>:<page-range>1261&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bcp.2012.01.026</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>CP</given-names>
</name>
<etal/>
</person-group>. <article-title>Decreased endogenous hydrogen sulfide generation in penile tissues of diabetic rats with erectile dysfunction</article-title>. <source>J Sex Med</source>. (<year>2016</year>) <volume>13</volume>:<page-range>350&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jsxm.2016.01.002</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yetik-Anacak</surname> <given-names>G</given-names>
</name>
<name>
<surname>Dikmen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Coletta</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mitidieri</surname> <given-names>E</given-names>
</name>
<name>
<surname>Dereli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Donnarumma</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen sulfide compensates nitric oxide deficiency in murine corpus cavernosum</article-title>. <source>Pharmacol Res</source>. (<year>2016</year>) <volume>113</volume>:<fpage>38</fpage>&#x2013;<lpage>43</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2016.08.015</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aydinoglu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Dalkir</surname> <given-names>FT</given-names>
</name>
<name>
<surname>Demirbag</surname> <given-names>HO</given-names>
</name>
<name>
<surname>Ogulener</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>The interaction of l-cysteine/H2S pathway and muscarinic acetylcholine receptors (mAChRs) in mouse corpus cavernosum</article-title>. <source>Nitric. Oxide</source>. (<year>2017</year>) <volume>70</volume>:<page-range>51&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.niox.2017.08.005</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>K</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Hydrogen sulfide represses androgen receptor transactivation by targeting at the second zinc finger module</article-title>. <source>J Biol Chem</source>. (<year>2014</year>) <volume>289</volume>:<page-range>20824&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M114.559518</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugiura</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kashiba</surname> <given-names>M</given-names>
</name>
<name>
<surname>Maruyama</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hoshikawa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sasaki</surname> <given-names>R</given-names>
</name>
<name>
<surname>Saito</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Cadmium exposure alters metabolomics of sulfur-containing amino acids in rat testes</article-title>. <source>Antioxid Redox Signal</source>. (<year>2005</year>) <volume>7</volume>:<page-range>781&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/ars.2005.7.781</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>G</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>ZZ</given-names>
</name>
<name>
<surname>Chua</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Bian</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Hydrogen sulfide protects testicular germ cells against heat-induced injury</article-title>. <source>Nitric. Oxide</source>. (<year>2015</year>) <volume>46</volume>:<page-range>165&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.niox.2014.10.005</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mou</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Endogenous hydrogen sulfide as a mediator of vas deferens smooth muscle relaxation</article-title>. <source>Fertil. Steril</source>. (<year>2011</year>) <volume>95</volume>:<page-range>1833&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fertnstert.2010.11.001</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>DD</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>WB</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>ZE</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>LL</given-names>
</name>
<etal/>
</person-group>. <article-title>Cellular mechanism underlying hydrogen sulfide mediated epithelial K+ Secretion in rat epididymis</article-title>. <source>Front Physiol</source>. (<year>2019</year>) <volume>9</volume>:<elocation-id>1886</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphys.2018.01886</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dean</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Lue</surname> <given-names>TF</given-names>
</name>
</person-group>. <article-title>Physiology of penile erection and pathophysiology of erectile dysfunction</article-title>. <source>Urol. Clin North. Am</source>. (<year>2005</year>) <volume>32</volume>:<page-range>379&#x2013;v</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ucl.2005.08.007</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geng</surname> <given-names>B</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2004</year>) <volume>318</volume>:<page-range>756&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2004.04.094</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srilatha</surname> <given-names>B</given-names>
</name>
<name>
<surname>Adaikan</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>PK</given-names>
</name>
</person-group>. <article-title>Possible role for the novel gasotransmitter hydrogen sulphide in erectile dysfunction&#x2013;a pilot study</article-title>. <source>Eur J Pharmacol</source>. (<year>2006</year>) <volume>535</volume>:<page-range>280&#x2013;2</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2006.02.001</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jupiter</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Yoo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Pankey</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Reddy</surname> <given-names>VV</given-names>
</name>
<name>
<surname>Edward</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Polhemus</surname> <given-names>DJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Analysis of erectile responses to H2S donors in the anesthetized rat</article-title>. <source>Am J Physiol Heart. Circ Physiol</source>. (<year>2015</year>) <volume>309</volume>:<page-range>H835&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpheart.00293.2015</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ganesan Adaikan</surname> <given-names>P</given-names>
</name>
<name>
<surname>Srilatha</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Hydrogen sulfide promotes nitric oxide production in corpus cavernosum by enhancing expression of endothelial nitric oxide synthase</article-title>. <source>Int J Impot. Res</source>. (<year>2013</year>) <volume>25</volume>:<fpage>86</fpage>&#x2013;<lpage>90</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ijir.2012.39</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aydinoglu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ad&#x131;belli</surname> <given-names>E&#xd6;</given-names>
</name>
<name>
<surname>Y&#x131;lmaz-Oral</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ogulener</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Involvement of RhoA/Rho-kinase in l-cysteine/H2S pathway-induced inhibition of agonist-mediated corpus cavernosal smooth muscle contraction</article-title>. <source>Nitric. Oxide</source>. (<year>2019</year>) <volume>85</volume>:<fpage>54</fpage>&#x2013;<lpage>60</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.niox.2019.02.001</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd Elmoneim</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sharabi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mohy El Din</surname> <given-names>M</given-names>
</name>
<name>
<surname>Louedec</surname> <given-names>L</given-names>
</name>
<name>
<surname>Norel</surname> <given-names>X</given-names>
</name>
<name>
<surname>Senbel</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Potassium channels modulate the action but not the synthesis of hydrogen sulfide in rat corpus cavernosum</article-title>. <source>Life Sci</source>. (<year>2017</year>) <volume>189</volume>:<fpage>39</fpage>&#x2013;<lpage>43</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2017.09.013</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yilmaz</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kaya-Sezginer</surname> <given-names>E</given-names>
</name>
<name>
<surname>Yilmaz-Oral</surname> <given-names>D</given-names>
</name>
<name>
<surname>Cengiz</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bayatli</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gur</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Effects of hydrogen sulphide donor, sodium hydrosulphide treatment on the erectile dysfunction in L-NAME-induced hypertensive rats</article-title>. <source>Andrologia</source>. (<year>2019</year>) <volume>51</volume>:<elocation-id>e13240</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/and.13240</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mostafa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Rashed</surname> <given-names>L</given-names>
</name>
<name>
<surname>Nabil</surname> <given-names>N</given-names>
</name>
<name>
<surname>Abo-Sief</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Mohamed</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Omar</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>Cavernosal hydrogen sulfide levels are associated with nitric oxide and hemeoxygenase levels in diabetic rats</article-title>. <source>Int J Impot. Res</source>. (<year>2019</year>) <volume>31</volume>:<page-range>105&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41443-018-0084-9</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname> <given-names>Q</given-names>
</name>
<name>
<surname>He</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hui</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Administration of H2S improves erectile dysfunction by inhibiting phenotypic modulation of corpus cavernosum smooth muscle in bilateral cavernous nerve injury rats</article-title>. <source>Nitric. Oxide</source>. (<year>2021</year>) <volume>107</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.niox.2020.11.003</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qabazard</surname> <given-names>B</given-names>
</name>
<name>
<surname>Yousif</surname> <given-names>MHM</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>OA</given-names>
</name>
</person-group>. <article-title>Alleviation of impaired reactivity in the corpus cavernosum of STZ-diabetic rats by slow-release H2S donor GYY4137</article-title>. <source>Int J Impot. Res</source>. (<year>2019</year>) <volume>31</volume>:<page-range>111&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41443-018-0083-x</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qabazard</surname> <given-names>B</given-names>
</name>
<name>
<surname>Yousif</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mousa</surname> <given-names>A</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>OA</given-names>
</name>
</person-group>. <article-title>GYY4137 attenuates functional impairment of corpus cavernosum and reduces fibrosis in rats with STZ-induced diabetes by inhibiting the TGF-&#x3b2;1/Smad/CTGF pathway</article-title>. <source>Biomed Pharmacother</source>. (<year>2021</year>) <volume>138</volume>:<fpage>111486</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2021.111486</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukami</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sekiguchi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Yasukawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Asano</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kasamatsu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ueda</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells</article-title>. <source>Biochem Pharmacol</source>. (<year>2015</year>) <volume>97</volume>:<page-range>300&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bcp.2015.08.005</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>WD</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>PF</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>YN</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen Sulfide and/or Ammonia Reduces Spermatozoa Motility through AMPK/AKT Related Pathways</article-title>. <source>Sci Rep</source>. (<year>2016</year>) <volume>6</volume>:<fpage>37884</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep37884</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bozkurt</surname> <given-names>M</given-names>
</name>
<name>
<surname>Degirmentepe</surname> <given-names>RB</given-names>
</name>
<name>
<surname>Polat</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Yildirim</surname> <given-names>F</given-names>
</name>
<name>
<surname>Sonmez</surname> <given-names>K</given-names>
</name>
<name>
<surname>Cekmen</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Protective effect of hydrogen sulfide on experimental testicular ischemia reperfusion in rats</article-title>. <source>J Pediatr Urol</source>. (<year>2020</year>) <volume>16</volume>:<page-range>40.e1&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpurol.2019.10.006</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>S</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Endogenous hydrogen sulfide counteracts polystyrene nanoplastics-induced mitochondrial apoptosis and excessive autophagy via regulating Nrf2 and PGC-1&#x3b1; signaling pathway in mouse spermatocyte-derived GC-2spd(ts) cells</article-title>. <source>Food Chem Toxicol</source>. (<year>2022</year>) <volume>164</volume>:<fpage>113071</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fct.2022.113071</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>H2S catalysed by CBS regulates testosterone synthesis through affecting the sulfhydrylation of PDE</article-title>. <source>J Cell Mol Med</source>. (<year>2021</year>) <volume>25</volume>:<page-range>3460&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcmm.16428</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Han</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen sulfide as a potential target in preventing spermatogenic failure and testicular dysfunction</article-title>. <source>Antioxid Redox Signal</source>. (<year>2018</year>) <volume>28</volume>:<page-range>1447&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/ars.2016.6968</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pintus</surname> <given-names>E</given-names>
</name>
<name>
<surname>Jovi&#x10d;i&#x107;</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kadlec</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ros-Santaella</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Divergent effect of fast- and slow-releasing HS donors on boar spermatozoa under oxidative stress</article-title>. <source>Sci Rep</source>. (<year>2020</year>) <volume>10</volume>:<fpage>6508</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-63489-4</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname> <given-names>YQ</given-names>
</name>
<name>
<surname>Ning</surname> <given-names>JZ</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>F</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Rao</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ruan</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>GYY4137 a H2S donor, attenuates ipsilateral epididymis injury in experimentally varicocele-induced rats via activation of the PI3K/Akt pathway</article-title>. <source>Iran. J Basic. Med Sci</source>. (<year>2019</year>) <volume>22</volume>:<page-range>729&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.22038/ijbms.2019.30588.7372</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>H2S relaxes vas deferens smooth muscle by modulating the large conductance Ca2+ -activated K+ (BKCa) channels via a redox mechanism</article-title>. <source>J Sex Med</source>. (<year>2012</year>) <volume>9</volume>:<page-range>2806&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1743-6109.2012.02879.x</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sullivan</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Dashwood</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Jeremy</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Morgan</surname> <given-names>RJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Nitric oxide and erection: is erectile dysfunction another manifestation of vascular disease</article-title>? <source>Cardiovasc Res</source>. (<year>1999</year>) <volume>43</volume>:<page-range>6580&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0008-6363(99)00135-2</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>F&#xf6;rstermann</surname> <given-names>U</given-names>
</name>
<name>
<surname>Gath</surname> <given-names>I</given-names>
</name>
<name>
<surname>Schwarz</surname> <given-names>P</given-names>
</name>
<name>
<surname>Closs</surname> <given-names>EI</given-names>
</name>
<name>
<surname>Kleinert</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control</article-title>. <source>Biochem Pharmacol</source>. (<year>1995</year>) <volume>50</volume>:<page-range>1321&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0006-2952(95)00181-6</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murad</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Nitric oxide and cyclic guanosine monophosphate signaling in the eye</article-title>. <source>Can J Ophthalmol</source>. (<year>2008</year>) <volume>43</volume>:<page-range>291&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1139/I08-044</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hosoki</surname> <given-names>R</given-names>
</name>
<name>
<surname>Matsuki</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kimura</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>1997</year>) <volume>237</volume>:<page-range>527&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/bbrc.1997.6878</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bucci</surname> <given-names>M</given-names>
</name>
<name>
<surname>Papapetropoulos</surname> <given-names>A</given-names>
</name>
<name>
<surname>Vellecco</surname> <given-names>V</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Pyriochou</surname> <given-names>A</given-names>
</name>
<name>
<surname>Roussos</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity, Arterioscler</article-title>. <source>Thromb Vasc Biol</source>. (<year>2010</year>) <volume>30</volume>:<fpage>1998</fpage>&#x2013;<lpage>2004</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/ATVBAHA.110.209783</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>La Fuente</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pepe-Cardoso</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Salamanca</surname> <given-names>JI</given-names>
</name>
<name>
<surname>Louro</surname> <given-names>N</given-names>
</name>
<name>
<surname>Angulo</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>L-cysteine/hydrogen sulfide pathway induces cGMP-dependent relaxation of corpus cavernosum and penile arteries from patients with erectile dysfunction and improves arterial vasodilation induced by PDE5 inhibition</article-title>. <source>Eur J Pharmacol</source>. (<year>2019</year>) <volume>863</volume>:<fpage>172675</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2019.172675</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Quayle</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Physiological roles and properties of potassium channels in arterial smooth muscle</article-title>. <source>Am J Physiol</source>. (<year>1995</year>) <volume>268</volume>:<page-range>C799&#x2013;822</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpcell.1995.268.4.C799</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christ</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Spray</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Brink</surname> <given-names>PR</given-names>
</name>
</person-group>. <article-title>Characterization of K currents in cultured human corporal smooth muscle cells</article-title>. <source>J Androl</source>. (<year>1993</year>) <volume>14</volume>:<page-range>319&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/j.1939-4640.1993.tb00392.x</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>CO</given-names>
</name>
</person-group>. <article-title>Inhibition of Na+&#x2013;K+ pump and L-type Ca2+ channel by glibenclamide in Guinea pig ventricular myocytes</article-title>. <source>J Pharmacol Exp Ther</source>. (<year>2005</year>) <volume>312</volume>:<page-range>61&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1124/jpet.104.074369</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ridley</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Rho family proteins: coordinating cell responses</article-title>. <source>Trends. Cell Biol</source>. (<year>2001</year>) <volume>11</volume>:<page-range>471&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0962-8924(01)02153-5</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ichikawa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Isaka</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nishikawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hartshorne</surname> <given-names>DJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase, J</article-title>. <source>Biol Chem</source>. (<year>1999</year>) <volume>274</volume>:<page-range>37385&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.274.52.37385</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somlyo</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Somlyo</surname> <given-names>AV</given-names>
</name>
</person-group>. <article-title>Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle</article-title>. <source>J Muscle. Res Cell Motil</source>. (<year>2004</year>) <volume>25</volume>:<page-range>613&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1023/B:JURE.0000038362.84697.c0</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chitaley</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wingard</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Clinton Webb</surname> <given-names>R</given-names>
</name>
<name>
<surname>Branam</surname> <given-names>H</given-names>
</name>
<name>
<surname>Stopper</surname> <given-names>VS</given-names>
</name>
<name>
<surname>Lewis</surname> <given-names>RW</given-names>
</name>
<etal/>
</person-group>. <article-title>Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway</article-title>. <source>Nat Med</source>. (<year>2001</year>) <volume>7</volume>:<page-range>119&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/83258</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aydinoglu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ogulener</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>The role of arachidonic acid/cyclooxygenase cascade, phosphodiesterase IV and Rho-kinase in H2S-induced relaxation in the mouse corpus cavernosum, Pharmacol</article-title>. <source>Rep</source>. (<year>2017</year>) <volume>69</volume>:<page-range>610&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pharep.2017.02.018</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Dillon</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Matson</surname> <given-names>JB</given-names>
</name>
</person-group>. <article-title>A review of hydrogen sulfide (HS) donors: Chemistry and potential therapeutic applications</article-title>. <source>Biochem Pharmacol</source>. (<year>2018</year>) <volume>149</volume>:<page-range>110&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bcp.2017.11.014</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Besiroglu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Otunctemur</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ozbek</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies</article-title>. <source>J Sex Med</source>. (<year>2015</year>) <volume>12</volume>:<page-range>1309&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jsm.12885</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salonia</surname> <given-names>A</given-names>
</name>
<name>
<surname>Burnett</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Graefen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hatzimouratidis</surname> <given-names>K</given-names>
</name>
<name>
<surname>Montorsi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mulhall</surname> <given-names>JP</given-names>
</name>
<etal/>
</person-group>. <article-title>Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function</article-title>. <source>Eur Urol</source>. (<year>2012</year>) <volume>62</volume>:<page-range>273&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.eururo.2012.04.047</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cirino</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sorrentino</surname> <given-names>R</given-names>
</name>
<name>
<surname>di Villa Bianca</surname> <given-names>R.d</given-names>
</name>
<name>
<surname>Popolo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Palmieri</surname> <given-names>A</given-names>
</name>
<name>
<surname>Imbimbo</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function</article-title>. <source>Proc Natl Acad Sci U. S. A</source>. (<year>2003</year>) <volume>100</volume>:<page-range>5531&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0931347100</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitidieri</surname> <given-names>E</given-names>
</name>
<name>
<surname>Tramontano</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gurgone</surname> <given-names>D</given-names>
</name>
<name>
<surname>Imbimbo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mirone</surname> <given-names>V</given-names>
</name>
<name>
<surname>Fusco</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>&#x3b2;3 adrenergic receptor activation relaxes human corpus cavernosum and penile artery through a hydrogen sulfide/cGMP-dependent mechanism</article-title>. <source>Pharmacol Res</source>. (<year>2017</year>) <volume>124</volume>:<page-range>100&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2017.07.025</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gur</surname> <given-names>S</given-names>
</name>
<name>
<surname>Peak</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yafi</surname> <given-names>FA</given-names>
</name>
<name>
<surname>Kadowitz</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Sikka</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Hellstrom</surname> <given-names>WJ</given-names>
</name>
</person-group>. <article-title>Mirabegron causes relaxation of human and rat corpus cavernosum: could it be a potential therapy for erectile dysfunction</article-title>? <source>BJU. Int</source>. (<year>2016</year>) <volume>118</volume>:<page-range>464&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/bju.13515</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>La Fuente</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Sevilleja-Ortiz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Garc&#xed;a-Rojo</surname> <given-names>E</given-names>
</name>
<name>
<surname>El Assar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pepe-Cardoso</surname> <given-names>AJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Erectile dysfunction is associated with defective L-cysteine/hydrogen sulfide pathway in human corpus cavernosum and penile arteries</article-title>. <source>Eur J Pharmacol</source>. (<year>2020</year>) <volume>884</volume>:<fpage>173370</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2020.173370</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Q</given-names>
</name>
<name>
<surname>He</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Sodium tanshinone IIA sulfonate attenuates erectile dysfunction in rats with hyperlipidemia</article-title>. <source>Oxid Med Cell Longev</source>. (<year>2020</year>) <volume>2020</volume>:<fpage>7286958</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2020/7286958</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukla</surname> <given-names>N</given-names>
</name>
<name>
<surname>Rossoni</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hotston</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sparatore</surname> <given-names>A</given-names>
</name>
<name>
<surname>Del Soldato</surname> <given-names>P</given-names>
</name>
<name>
<surname>Tazzari</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats</article-title>. <source>BJU. Int</source>. (<year>2009</year>) <volume>103</volume>:<page-range>1522&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1464-410X.2009.08415.x</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yetik-Anacak</surname> <given-names>G</given-names>
</name>
<name>
<surname>Dereli</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Sevin</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ozzay&#x131;m</surname> <given-names>O</given-names>
</name>
<name>
<surname>Erac</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Resveratrol stimulates hydrogen sulfide (H2S) formation to relax murine corpus cavernosum</article-title>. <source>J Sex Med</source>. (<year>2015</year>) <volume>12</volume>:<page-range>2004&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jsm.12993</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dayar</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kara</surname> <given-names>E</given-names>
</name>
<name>
<surname>Yetik-Anacak</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hocaoglu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bozkurt</surname> <given-names>O</given-names>
</name>
<name>
<surname>Gidener</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Do penile haemodynamics change in the presence of hydrogen sulphide (H2 S) donor in metabolic syndrome-induced erectile dysfunction</article-title>? <source>Andrologia</source>. (<year>2018</year>) <volume>50</volume>(<issue>3</issue>):<page-range>10.1111/and.12885</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/and.12885</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yilmaz-Oral</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kaya-Sezginer</surname> <given-names>E</given-names>
</name>
<name>
<surname>Oztekin</surname> <given-names>CV</given-names>
</name>
<name>
<surname>Bayatli</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lokman</surname> <given-names>U</given-names>
</name>
<name>
<surname>Gur</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type-5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model</article-title>. <source>Neurourol. Urodyn</source>. (<year>2020</year>) <volume>39</volume>:<page-range>1087&#x2013;97</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/nau.24333</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desai</surname> <given-names>K</given-names>
</name>
<name>
<surname>McManus</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Sharifi</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Hormonal therapy for prostate cancer</article-title>. <source>Endocr. Rev</source>. (<year>2021</year>) <volume>42</volume>:<page-range>354&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endrev/bnab002</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lonergan</surname> <given-names>PE</given-names>
</name>
<name>
<surname>Tindall</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>Androgen receptor signaling in prostate cancer development and progression</article-title>. <source>J Carcinog</source>. (<year>2011</year>) <volume>10</volume>:<fpage>20</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/1477-3163.83937</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Alabi</surname> <given-names>BR</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Stoyanova</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Molecular mechanisms underlying the development of neuroendocrine prostate cancer</article-title>. <source>Semin Cancer. Biol</source>. (<year>2022</year>) <volume>86</volume>:<fpage>57</fpage>&#x2013;<lpage>68</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.semcancer.2022.05.007</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariot</surname> <given-names>P</given-names>
</name>
<name>
<surname>Vanoverberghe</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lalevee</surname> <given-names>N</given-names>
</name>
<name>
<surname>Rossier</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Prevarskaya</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Prevarskaya, Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells</article-title>. <source>J Biol Chem</source>. (<year>2002</year>) <volume>277</volume>:<page-range>10824&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M108754200</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gacki&#xe8;re</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bidaux</surname> <given-names>G</given-names>
</name>
<name>
<surname>Delcourt</surname> <given-names>P</given-names>
</name>
<name>
<surname>Van Coppenolle</surname> <given-names>F</given-names>
</name>
<name>
<surname>Katsogiannou</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dewailly</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>CaV3.2 T-type calcium channels are involved in calciumdependent secretion of neuroendocrine prostate cancer cells</article-title>. <source>J Biol Chem</source>. (<year>2008</year>) <volume>283</volume>:<page-range>10162&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M707159200</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ngowi</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Afzal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sarfraz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khattak</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zaman</surname> <given-names>SU</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>NH</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of hydrogen sulfide donors in cancer development and progression</article-title>. <source>Int J Biol Sci</source>. (<year>2021</year>) <volume>17</volume>:<fpage>73</fpage>&#x2013;<lpage>88</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/ijbs.47850</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chattopadhyay</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kodela</surname> <given-names>R</given-names>
</name>
<name>
<surname>Nath</surname> <given-names>N</given-names>
</name>
<name>
<surname>Dastagirzada</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Vel&#xe1;zquez-Mart&#xed;nez</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Boring</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect</article-title>. <source>Biochem Pharmacol</source>. (<year>2012</year>) <volume>83</volume>:<page-range>715&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bcp.2011.12.018</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bigagli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Luceri</surname> <given-names>C</given-names>
</name>
<name>
<surname>De Angioletti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chegaev</surname> <given-names>K</given-names>
</name>
<name>
<surname>D&#x2019;Ambrosio</surname> <given-names>M</given-names>
</name>
<name>
<surname>Riganti</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in <italic>vitro</italic> and in <italic>vivo</italic> evaluations</article-title>. <source>Invest. New. Drugs</source>. (<year>2018</year>) <volume>36</volume>:<page-range>985&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10637-018-0590-0</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>B</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>BX</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>WY</given-names>
</name>
<name>
<surname>Gan</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Zn2+-interference and H2S-mediated gas therapy based on ZnS-tannic acid nanoparticles synergistic enhancement of cell apoptosis for specific treatment of prostate cancer</article-title>. <source>Colloids. Surf. B Biointerfaces</source>. (<year>2023</year>) <volume>226</volume>:<fpage>113313</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.colsurfb.2023.113313</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Min</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Decrease in male mouse fertility by hydrogen sulfide and/or ammonia can Be inheritable</article-title>. <source>Chemosphere</source>. (<year>2018</year>) <volume>194</volume>:<page-range>147&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chemosphere.2017.11.164</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moustafa</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Changes in nitric oxide, carbon monoxide, hydrogen sulfide and male reproductive hormones in response to chronic restraint stress in rats</article-title>. <source>Free. Radic Biol Med</source>. (<year>2021</year>) <volume>162</volume>:<page-range>353&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2020.10.315</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ameli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ahmadzadeh</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khajavi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nabizadeh</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Evaluation of the success rate and complications of conventional varicocelectomy: Do we need microscopic surgery really</article-title>? <source>Urologia</source>. (<year>2019</year>) <volume>86</volume>:<page-range>23&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0391560318758938</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lorian</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kadkhodaee</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kianian</surname> <given-names>F</given-names>
</name>
<name>
<surname>Abdi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ranjbaran</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ashabi</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Long-term NaHS administration reduces oxidative stress and apoptosis in a rat model of left-side varicocele</article-title>. <source>Andrologia</source>. (<year>2020</year>) <volume>52</volume>:<elocation-id>e13496</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/and.13496</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shafie</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kianian</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ashabi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Kadkhodaee</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ranjbaran</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hajiaqaei</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Beneficial effects of combination therapy with testosterone and hydrogen sulfide by reducing oxidative stress and apoptosis: Rat experimental varicocele model</article-title>. <source>Int J Reprod BioMed</source>. (<year>2022</year>) <volume>20</volume>:<page-range>941&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.18502/ijrm.v20i11.12362</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fallahzadeh</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Rezaei</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Rahimi</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Barmak</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Sadeghi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mehrabi</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluation of the effect of pentoxifylline on cisplatin-induced testicular toxicity in rats</article-title>. <source>Toxicol Res</source>. (<year>2017</year>) <volume>33</volume>:<page-range>255&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.5487/TR.2017.33.3.255</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azarbarz</surname> <given-names>N</given-names>
</name>
<name>
<surname>Shafiei Seifabadi</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Moaiedi</surname> <given-names>MZ</given-names>
</name>
<name>
<surname>Mansouri</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Assessment of the effect of sodium hydrogen sulfide (hydrogen sulfide donor) on cisplatin-induced testicular toxicity in rats</article-title>. <source>Environ Sci pollut Res Int</source>. (<year>2020</year>) <volume>27</volume>:<page-range>8119&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11356-019-07266-5</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amereh</surname> <given-names>F</given-names>
</name>
<name>
<surname>Babaei</surname> <given-names>M</given-names>
</name>
<name>
<surname>Eslami</surname> <given-names>A</given-names>
</name>
<name>
<surname>Fazelipour</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rafiee</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The emerging risk of exposure to nano(micro)plastics on endocrine disturbance and reproductive toxicity: from a hypothetical scenario to a global public health challenge</article-title>. <source>Environ pollut</source>. (<year>2020</year>) <volume>261</volume>:<fpage>114158</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.envpol.2020.114158</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>R</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Enhanced reproductive toxicities induced by phthalates contaminated microplastics in male mice (Mus musculus)</article-title>. <source>J Hazard. Mater</source>. (<year>2021</year>) <volume>406</volume>:<fpage>124644</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jhazmat.2020.124644</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohlander</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Lindgren</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Lipshultz</surname> <given-names>LI</given-names>
</name>
</person-group>. <article-title>Testosterone and male infertility</article-title>. <source>Urol. Clin North. Am</source>. (<year>2016</year>) <volume>43</volume>:<fpage>195</fpage>&#x2013;<lpage>202</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ucl.2016.01.006</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>QY</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>CX</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>QY</given-names>
</name>
<etal/>
</person-group>. <article-title>ROS-induced oxidative stress is a major contributor to sperm cryoinjury</article-title>. <source>Hum Reprod</source>. (<year>2023</year>) <volume>39</volume>(<issue>2</issue>):<page-range>310&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/dead250</pub-id>
</citation>
</ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wili&#x144;ski</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wili&#x144;ski</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gajda</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jasek</surname> <given-names>E</given-names>
</name>
<name>
<surname>Somogyi</surname> <given-names>E</given-names>
</name>
<name>
<surname>G&#x142;owacki</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Sodium hydrosulfide exerts a transitional attenuating effect on spermatozoa migration in vitro</article-title>. <source>Folia. Biol (Krakow)</source>. (<year>2015</year>) <volume>63</volume>:<page-range>145&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3409/fb63_2.145</pub-id>
</citation>
</ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadlec</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pintus</surname> <given-names>E</given-names>
</name>
<name>
<surname>Ros-Santaella</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>The interaction of NO and H2S in boar spermatozoa under oxidative stress</article-title>. <source>Anim (Basel)</source>. (<year>2022</year>) <volume>12</volume>:<fpage>602</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ani12050602</pub-id>
</citation>
</ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pintus</surname> <given-names>E</given-names>
</name>
<name>
<surname>Chinn</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Kadlec</surname> <given-names>M</given-names>
</name>
<name>
<surname>Garc&#xed;a-V&#xe1;zquez</surname> <given-names>FA</given-names>
</name>
<name>
<surname>Novy</surname> <given-names>P</given-names>
</name>
<name>
<surname>Matson</surname> <given-names>JB</given-names>
</name>
<etal/>
</person-group>. <article-title>N-thiocarboxyanhydrides, amino acid-derived enzyme-activated H2S donors, enhance sperm mitochondrial activity in presence and absence of oxidative stress</article-title>. <source>BMC. Vet Res</source>. (<year>2023</year>) <volume>19</volume>:<fpage>52</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12917-023-03593-5</pub-id>
</citation>
</ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Murdoch</surname> <given-names>RN</given-names>
</name>
</person-group>. <article-title>Regulation ofthe motility and metabolism of spermatozoa for storage in the epididymis of eutherian and marsupial mammals</article-title>. <source>Reprod Fertil. Dev</source>. (<year>1996</year>) <volume>8</volume>:<page-range>553&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1071/RD9960553</pub-id>
</citation>
</ref>
<ref id="B106">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D&#x2019;Ancona</surname> <given-names>C</given-names>
</name>
<name>
<surname>Haylen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Oelke</surname> <given-names>M</given-names>
</name>
<name>
<surname>Abranches-Monteiro</surname> <given-names>L</given-names>
</name>
<name>
<surname>Arnold</surname> <given-names>E</given-names>
</name>
<name>
<surname>Goldman</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction</article-title>. <source>Neurourol. Urodyn</source>. (<year>2019</year>) <volume>38</volume>:<page-range>433&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/nau.23897</pub-id>
</citation>
</ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdelmoteleb</surname> <given-names>H</given-names>
</name>
<name>
<surname>Jefferies</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Drake</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Assessment and management of male lower urinary tract symptoms (LUTS)</article-title>. <source>Int J Surg</source>. (<year>2016</year>) <volume>25</volume>:<page-range>164&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijsu.2015.11.043</pub-id>
</citation>
</ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Nunzio</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lombardo</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tema</surname> <given-names>G</given-names>
</name>
<name>
<surname>Tubaro</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Erectile dysfunction and lower urinary tract symptoms</article-title>. <source>Curr Uro.l Rep</source>. (<year>2018</year>) <volume>19</volume>:<fpage>61</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11934-018-0817-9</pub-id>
</citation>
</ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gkatzoudi</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bouloukaki</surname> <given-names>I</given-names>
</name>
<name>
<surname>Mamoulakis</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lionis</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tsiligianni</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Evaluation of lower urinary tract symptoms in males and urinary incontinence in females in primary health care in Greece</article-title>. <source>Medicina (Kaunas)</source>. (<year>2024</year>) <volume>60</volume>:<fpage>389</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/medicina60030389</pub-id>
</citation>
</ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Przydacz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Osman</surname> <given-names>N</given-names>
</name>
<name>
<surname>De Cillis</surname> <given-names>S</given-names>
</name>
<name>
<surname>Guillot-Tantay</surname> <given-names>C</given-names>
</name>
<name>
<surname>Herve</surname> <given-names>F</given-names>
</name>
<name>
<surname>H&#xfc;sch</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Overactive bladder negatively affects erectile function and promotes premature ejaculation: findings from large representative population-level study</article-title>. <source>World. J Urol</source>. (<year>2024</year>) <volume>42</volume>:<fpage>139</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00345-024-04841-5</pub-id>
</citation>
</ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomelsky</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>EF</given-names>
</name>
<name>
<surname>Dalton</surname> <given-names>DC</given-names>
</name>
</person-group>. <article-title>Combination treatment for male lower urinary tract symptoms with anticholinergic and alpha-blockers</article-title>. <source>Curr Opin Urol</source>. (<year>2018</year>) <volume>28</volume>:<page-range>277&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MOU.0000000000000489</pub-id>
</citation>
</ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Groat</surname> <given-names>WC</given-names>
</name>
<name>
<surname>Griffiths</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yoshimura</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Neural control of the lower urinary tract</article-title>. <source>Compr Physiol</source>. (<year>2015</year>) <volume>5</volume>:<page-range>327&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cphy.c130056</pub-id>
</citation>
</ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patacchini</surname> <given-names>R</given-names>
</name>
<name>
<surname>Santicioli</surname> <given-names>P</given-names>
</name>
<name>
<surname>Giuliani</surname> <given-names>S</given-names>
</name>
<name>
<surname>Maggi</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>Hydrogen sulfide (H2S) stimulates capsaicin-sensitive primary afferent neurons in the rat urinary bladder</article-title>. <source>Br J Pharmacol</source>. (<year>2004</year>) <volume>142</volume>:<page-range>31&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.bjp.0705764</pub-id>
</citation>
</ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname> <given-names>VS</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Barahona</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Orensanz</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Mart&#xed;nez-S&#xe1;enz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Recio</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen sulfide mediated inhibitory neurotransmission to the pig bladder neck: role of KATP channels, sensory nerves and calcium signaling</article-title>. <source>J Urol</source>. (<year>2013</year>) <volume>190</volume>:<page-range>746&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.juro.2013.02.103</pub-id>
</citation>
</ref>
<ref id="B115">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname> <given-names>VS</given-names>
</name>
<name>
<surname>Xin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Petkov</surname> <given-names>GV</given-names>
</name>
</person-group>. <article-title>Novel mechanism of hydrogen sulfide-induced Guinea pig urinary bladder smooth muscle contraction: role of BK channels and cholinergic neurotransmission</article-title>. <source>Am J Physiol Cell Physiol</source>. (<year>2015</year>) <volume>309</volume>:<page-range>C107&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpcell.00021.2015</pub-id>
</citation>
</ref>
<ref id="B116">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname> <given-names>VS</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Orensanz</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Barahona</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Mart&#xed;nez-S&#xe1;enz</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Endogenous hydrogen sulfide has a powerful role in inhibitory neurotransmission to the pig bladder neck</article-title>. <source>J Urol</source>. (<year>2013</year>) <volume>189</volume>:<page-range>1567&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.juro.2012.10.006</pub-id>
</citation>
</ref>
<ref id="B117">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitidieri</surname> <given-names>E</given-names>
</name>
<name>
<surname>Pecoraro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Esposito</surname> <given-names>E</given-names>
</name>
<name>
<surname>Brancaleone</surname> <given-names>V</given-names>
</name>
<name>
<surname>Turnaturi</surname> <given-names>C</given-names>
</name>
<name>
<surname>Napolitano</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>&#x3b2;3 relaxant effect in human bladder involves cystathionine &#x3b3;-lyase-derived urothelial hydrogen sulfide</article-title>. <source>Antioxidants (Basel)</source>. (<year>2022</year>) <volume>11</volume>:<fpage>1480</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox11081480</pub-id>
</citation>
</ref>
<ref id="B118">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>d&#x2019;Emmanuele</surname> <given-names>diVBR</given-names>
</name>
<name>
<surname>Mitidieri</surname> <given-names>E</given-names>
</name>
<name>
<surname>Fusco</surname> <given-names>F</given-names>
</name>
<name>
<surname>Russo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pagliara</surname> <given-names>V</given-names>
</name>
<name>
<surname>Tramontano</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Urothelium muscarinic activation phosphorylates CBS(Ser227) via cGMP/PKG pathway causing human bladder relaxation through H2S production</article-title>. <source>Sci Rep</source>. (<year>2016</year>) <volume>6</volume>:<fpage>31491</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep31491</pub-id>
</citation>
</ref>
<ref id="B119">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname> <given-names>ASF</given-names>
</name>
<name>
<surname>Fernandes</surname> <given-names>VS</given-names>
</name>
<name>
<surname>Mart&#xed;nez-S&#xe1;enz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname> <given-names>P</given-names>
</name>
<name>
<surname>Barahona</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Orensanz</surname> <given-names>LM</given-names>
</name>
<etal/>
</person-group>. <article-title>Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck</article-title>. <source>J Sex Med</source>. (<year>2014</year>) <volume>11</volume>:<page-range>930&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jsm.12456</pub-id>
</citation>
</ref>
<ref id="B120">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fusco</surname> <given-names>F</given-names>
</name>
<name>
<surname>D&#x2019;Anzeo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sessa</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pace</surname> <given-names>G</given-names>
</name>
<name>
<surname>Rossi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Capece</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>BPH/LUTS and ED: common pharmacological pathways for a common treatment</article-title>. <source>J Sex Med</source>. (<year>2013</year>) <volume>10</volume>:<page-range>2382&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jsm.12261</pub-id>
</citation>
</ref>
<ref id="B121">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fusco</surname> <given-names>F</given-names>
</name>
<name>
<surname>di Villa Bianca</surname> <given-names>R.d</given-names>
</name>
<name>
<surname>Mitidieri</surname> <given-names>E</given-names>
</name>
<name>
<surname>Cirino</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sorrentino</surname> <given-names>R</given-names>
</name>
<name>
<surname>Mirone</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors</article-title>. <source>Eur Urol</source>. (<year>2012</year>) <volume>62</volume>:<page-range>1174&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.eururo.2012.07.025</pub-id>
</citation>
</ref>
<ref id="B122">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agis-Torres</surname> <given-names>&#xc1;</given-names>
</name>
<name>
<surname>Recio</surname> <given-names>P</given-names>
</name>
<name>
<surname>L&#xf3;pez-Oliva</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Barahona</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Benedito</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Phosphodiesterase type 4 inhibition enhances nitric oxide- and hydrogen sulfide-mediated bladder neck inhibitory neurotransmission</article-title>. <source>Sci Rep</source>. (<year>2018</year>) <volume>8</volume>:<fpage>4711</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-018-22934-1</pub-id>
</citation>
</ref>
<ref id="B123">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeremy</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Rowe</surname> <given-names>D</given-names>
</name>
<name>
<surname>Emsley</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Newby</surname> <given-names>AC</given-names>
</name>
</person-group>. <article-title>Nitric oxide and vascular smooth muscle cell proliferation</article-title>. <source>Cardiovasc Res</source>. (<year>1999</year>) <volume>43</volume>:<page-range>580&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0008-6363(99)00171-6</pub-id>
</citation>
</ref>
<ref id="B124">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koupparis</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Jeremy</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Muzaffar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Angelini</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Shukla</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Sildenafil inhibits the formation of superoxide and the expression of gp47phox NADPH oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells</article-title>. <source>BJU. Int</source>. (<year>2005</year>) <volume>96</volume>:<page-range>423&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1464-410X.2005.05643.x</pub-id>
</citation>
</ref>
<ref id="B125">
<label>125</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukla</surname> <given-names>N</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>R</given-names>
</name>
<name>
<surname>Persad</surname> <given-names>R</given-names>
</name>
<name>
<surname>Angelini</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Jeremy</surname> <given-names>JY</given-names>
</name>
</person-group>. <article-title>Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits</article-title>. <source>Eur Pharmacol</source>. (<year>2005</year>) <volume>517</volume>:<page-range>224&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2005.05.012</pub-id>
</citation>
</ref>
<ref id="B126">
<label>126</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeremy</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Koupparis</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Hotston</surname> <given-names>M</given-names>
</name>
<name>
<surname>Persad</surname> <given-names>R</given-names>
</name>
<name>
<surname>Shukla</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase</article-title>. <source>Int J Impot. Res</source>. (<year>2007</year>) <volume>19</volume>:<page-range>265&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.ijir.3901523</pub-id>
</citation>
</ref>
<ref id="B127">
<label>127</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muzaffar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jeremy</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Angelini</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Stuart Smith</surname> <given-names>K</given-names>
</name>
<name>
<surname>Shukla</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>The role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries</article-title>. <source>Thorax</source>. (<year>2003</year>) <volume>58</volume>:<fpage>598</fpage>&#x2013;<lpage>604</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/thorax.58.7.598</pub-id>
</citation>
</ref>
<ref id="B128">
<label>128</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muzaffar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Shukla</surname> <given-names>N</given-names>
</name>
<name>
<surname>Angelini</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Jeremy</surname> <given-names>JY</given-names>
</name>
</person-group>. <article-title>Nitroaspirins and SIN-1, but not aspirin, inhibit the expression of endotoxin- and cytokine- induced NADPH oxidase in vascular smooth muscle cells from pig pulmonary arteries</article-title>. <source>Circulation</source>. (<year>2004</year>) <volume>110</volume>:<page-range>1140&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/01.CIR.0000139851.50067.E4</pub-id>
</citation>
</ref>
<ref id="B129">
<label>129</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hotston</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jeremy</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Bloor</surname> <given-names>J</given-names>
</name>
<name>
<surname>Greaves</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Persad</surname> <given-names>R</given-names>
</name>
<name>
<surname>Angelini</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Homocysteine and copper interact to promote type 5 phosphodiesterase expression in rabbit cavernosal smooth muscle cells</article-title>. <source>Asian. J Androl</source>. (<year>2008</year>) <volume>10</volume>:<page-range>905&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ajan.2008.10.issue-6</pub-id>
</citation>
</ref>
<ref id="B130">
<label>130</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muzaffar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Shukla</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bond</surname> <given-names>M</given-names>
</name>
<name>
<surname>Newby</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Angelini</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Sparatore</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac (1) activity in human vascular smooth muscle cells</article-title>. <source>J Vasc Res</source>. (<year>2008</year>) <volume>45</volume>:<page-range>521&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000129686</pub-id>
</citation>
</ref>
<ref id="B131">
<label>131</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bibli</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Topouzis</surname> <given-names>S</given-names>
</name>
<name>
<surname>Papapetropoulos</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Role of cGMP in hydrogen sulfide signaling</article-title>. <source>Nitric. Oxide</source>. (<year>2015</year>) <volume>46</volume>:<fpage>7</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.niox.2014.12.004</pub-id>
</citation>
</ref>
<ref id="B132">
<label>132</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muzaffar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Shukla</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bond</surname> <given-names>M</given-names>
</name>
<name>
<surname>Newby</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Angelini</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Jeremy</surname> <given-names>JY</given-names>
</name>
</person-group>. <article-title>Acute inhibition of superoxide formation and Rac (1) activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A (2) analogue, U46619</article-title>. <source>Prostaglandins Leukotr. Essent Fatty Acids</source>. (<year>2008</year>) <volume>78</volume>:<page-range>247&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.plefa.2008.01.008</pub-id>
</citation>
</ref>
<ref id="B133">
<label>133</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Post-translational modifications of Keap1: the state of the art</article-title>. <source>Front Cell Dev Biol</source>. (<year>2024</year>) <volume>11</volume>:<elocation-id>1332049</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2023.1332049</pub-id>
</citation>
</ref>
<ref id="B134">
<label>134</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mustafa</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Sikka</surname> <given-names>G</given-names>
</name>
<name>
<surname>Gazi</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Steppan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Bhunia</surname> <given-names>AK</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels</article-title>. <source>Circulation. Res</source>. (<year>2011</year>) <volume>109</volume>:<page-range>1259&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.240242</pub-id>
</citation>
</ref>
<ref id="B135">
<label>135</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Sulfhydration-associated phosphodiesterase 5A dimerization mediates vasorelaxant effect of hydrogen sulfide</article-title>. <source>Oncotarget</source>. (<year>2017</year>) <volume>8</volume>:<page-range>31888&#x2013;900</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/oncotarget.v8i19</pub-id>
</citation>
</ref>
<ref id="B136">
<label>136</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Centelles</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>KP</given-names>
</name>
</person-group>. <article-title>Making and working with hydrogen sulfide: the chemistry and generation of hydrogen sulfide in <italic>vitro</italic> and its measurement in <italic>vivo</italic>: a review</article-title>. <source>Free. Radic Biol Med</source>. (<year>2009</year>) <volume>47</volume>:<page-range>1346&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.09.018</pub-id>
</citation>
</ref>
<ref id="B137">
<label>137</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>deGroat</surname> <given-names>WC</given-names>
</name>
<name>
<surname>Booth</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>Physiology of male sexual function</article-title>. <source>Ann Intern Med</source>. (<year>1980</year>) <volume>92</volume>:<page-range>329&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7326/0003-4819-92-2-329</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>